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Congenital heart disease (CHD) is the most common congenital anomaly, which makes it 
a leading cause of infant mortality. Congenital heart defects are a cluster of distinct developmental 
malformations that affect the vasculature, musculature and organization of the heart, each with 
varying clinical severity. Although medical and surgical advances have reduced CHD mortality in 
newborns and children, these patients grow up and many experience serious morbidity and early 
mortality. The first step toward reducing this burden is to understand the causes of CHD. 
Surprisingly, environmental insults and de novo mutations are estimated to explain less than one-
third of CHD cases. In many cases, even when a vital cardiac gene is mutated, a heart defect does 
not occur. This highlights the critical role of genetic and environmental modifiers in CHD 
pathogenesis. Attempts to identify these modifiers have had marginal success in humans. This 
motivated us to model CHD in mice, in which we can control the effects of environment and 
genetics. 
Using nearly 20,000 Nkx2-5 heterozygous mutant mice from multiple inbred strain crosses, 
my work provides three key findings that describe how genetic and environmental risk factors 
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modulate CHD risk. First, severe heart defects are rare because they require interactions between 
multiple risk alleles to manifest disease. Contrarily, mild heart defects can be caused by the Nkx2-
5 mutation alone, which allows these defects to be common. Second, genetic robustness to 
deleterious mutations can result from well-integrated or coadapted genetic networks. In our mouse 
model, we found that epistatic interaction effects tend to suppress heart defect risk when the 
interacting alleles originate from the ancestral mouse strain. This suggests that the incomplete 
penetrance of human CHD-associated mutations is a result of varying levels of robustness to 
disease across individuals. Third, there is significant genetic variation in the maternal age 
associated risk of CHD, suggesting that the underlying genes can be identified. We recapitulated 
the human maternal age risk using a 56th generation advanced intercross mouse mother population 
and identified one genome-wide significant locus that modulates the age effect across different 
heart defect types. Modulating the associated molecular pathway may become a fruitful therapeutic 
target to suppress CHD risk. 
In conclusion, my work has uncovered multiple factors that contribute to congenital heart 
disease risk in humans. The importance of epistasis in CHD risk emphasizes the need to consider 
oligogenic disease models in whole-exome/genome and clinical genetics studies of CHD. 
Furthermore, maternal effects such as the maternal age effect may help identify modifiable 
molecular pathways that can suppress CHD risk in human populations. Future studies on the 
maternal age effect will focus on finalizing our statistical models and validating candidate genes 















Congenital heart disease (CHD) makes up one-third of all congenital defects, making it 
the most common birth defect. This does not include the number of cases that cause miscarriages 
and stillborn births. Outcomes for CHD cases have improved drastically over the past several 
decades because of innovative surgical techniques. However, the surgical interventions only delay 
morbidity and mortality. Studies show two-thirds of CHD patients are now adults and the number 
of hospital admissions for adult CHD complications exceed those of pediatric cases1,2. This 
highlights the need for new strategies that can prevent CHD altogether. Although molecular 
genetic techniques have been useful in identifying high penetrance CHD genes, most cases of CHD 
are sporadic and not associated with classical cardiac developmental genes. A better approach 
would be to identify genetic and molecular mechanisms that can be modified to reduce CHD risk. 
This introduction chapter will provide a historical perspective of CHD genetics and move toward 
present day techniques that are used to investigate complex genetic traits. Finally, this chapter will 
discuss how these concepts can be applied toward understanding the genetic determinants of CHD 
and potentially finding preventative interventions. 
 
A historical perspective on the genetics of congenital heart disease 
 The earliest records of congenital heart defects date back to the 1600s, but detailed studies 
did not begin until the 1800s3. In 1858, physician Thomas Bevill Peacock wrote the first 
comprehensive study on congenital heart disease (CHD) entitled, “On Malformations of the 
Human Heart.” In this monograph, Peacock was the first to suggest a hereditary predisposition to 
CHD, even before Mendel published his treatise on genetic inheritance4,5. Despite Peacock’s 
prescient assertion, other cardiologists focused on finding causative environmental factors or 
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developing surgical interventions because genetic studies were not feasible6. It was not until the 
mid-1900s that genetics became a focus in CHD research. In 1968, James Nora, a prominent 
pediatric cardiologist, proposed a multifactorial inheritance model of CHD7. He hypothesized that 
a heart defect is caused by a specific mixture of susceptibility genes combined with certain 
environmental stressors in the mother that shift an elevated genetic risk toward a true defect. This 
is still a popular hypothesis among pediatric cardiologists today.  
Helen Taussig, founder of the field of pediatric cardiology and co-inventor of the Blalock-
Thomas-Taussig shunt, did not completely agree with Nora. She found that human populations 
worldwide all had similar rates of CHD, so she discounted the influence of specific environmental 
stressors3. Furthermore, she compiled data showing that other mammals developed CHD at similar 
rates as human. At the end of her career, she proposed the idea that genetic elements common to 
all mammals influenced the risk of CHDs and the defects we see today are “primeval hearts— 
‘stepping stones’ in the evolution of the ‘normal’ heart”. She supports this idea by stating how 
certain heart defects do not reduce fitness as much, and therefore may permit the underlying 
genetic variants to escape selection. This theory is not widely popular today, but it spurred others 
to study cardiac development in other organisms with the hopes that their findings will recapitulate 
human development. 
 In the present age of molecular genetics, investigators have benefitted greatly from animal 
models. Animal models have facilitated the discovery of various critical transcription factors. In 
1993, Rolf Bodmer identified the homeobox gene, tinman, as a key factor responsible for cardiac 
specification in the drosophila visceral mesoderm8. Just a few months later, the mammalian 
orthologue, Nkx2-5 (Csx), was identified in mice9,10. Soon, several other cardiac transcription 
factors were identified in animals. It was not until 1998 that genome-wide linkage analysis proved 
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that NKX2-5 gene mutations caused CHD in humans11. Since then, more studies have linked over 
300 genes to the pathogenesis of CHD (Table 1.1). Surprisingly, only about 25% of CHD cases 
harbor de novo mutations in these genes12, suggesting that genetic polymorphisms in other genes 
are functionally significant in CHD pathogenesis (Figure 1.1). 
 The inheritance pattern for CHD has been difficult to decipher, partly because of variable 
penetrance of CHD-causing variants. Some have tried to approach this problem by studying the 
risk of CHD recurrence in the offspring when a parent also has a CHD. Sir John Burn and his 
colleagues used British CHD data and mathematical genetic models to determine that the various 
types of heart defects are inherited through different mechanisms; some are due to single gene 
influences, while others are caused by up to 100 genetic loci13. A series of studies conducted in 
Denmark showed that there is significant familial clustering of CHD, in general, but the specific 
CHD phenotypes found within families are highly discordant14,15. These studies suggest two non-
exclusive possibilities: (1) individuals with CHD inherit a single disease-causing locus and genetic 
variants at other loci control the penetrance and expressivity of the phenotype; (2) individuals 
inherit a combination of genetic factors that increase the risk of impaired heart development and 
the heart defect is determined by a combination of environmental and genetic modifiers. Although 
there may be overlap between the mechanisms of inheritance, the experimental approaches to 
discover CHD genes require a distinction between simple/Mendelian and complex/polygenic 
inheritance.  
 Simple Mendelian inheritance suggests a single genetic locus with a large effect on CHD 
risk. Classically, researchers approach this scenario using linkage analysis on family pedigrees. 
Linkage analysis is a form of genetic study that tracks recombination events between SNP markers, 
allowing the detection of the trait loci that are located close to the SNP marker because of linkage 
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disequilibrium16. Linkage disequilibrium (LD) is the tendency for physically close markers (on the 
same chromosome) to be inherited together17. Deviation from the expected 50% recombination 
required by the Law of Independent Assortment is called LD. The LD between SNP markers and 
the disease locus allows for statistical inferences that can determine its physical location. Modern 
linkage analysis requires SNP genotype data for probands, unaffected siblings and parents, and 
high-quality phenotype data for everyone. Including extended family members or other affected 
families can improve statistical power and reduce false positives16,18. Linkage analysis revealed 
the location of Mendelian mutations in genes such as NOTCH1, TBX5 and GATA4 because of the 
autosomal dominant inheritance pattern19-21. 
 In the early 2010s, genome-wide association studies (GWAS) were expected to unveil how 
common genetic variants affect risk for CHD. In simple terms, a GWAS is a regression of the 
phenotype on the genotypes at each locus. This quantifies how strongly each single nucleotide 
polymorphism (SNP) is associated with the phenotype of interest22. GWAS is particularly useful 
for traits with low penetrance or polygenic inheritance, with small phenotypic effect per locus. 
Though GWAS appeared very promising, it has yet to unearth new causal genes for CHD. Because 
the effect sizes of associated loci are usually small and there are often several loci to validate, it 
becomes difficult to hone in on the inciting gene or genetic network18. 
There have been two exemplary studies that tempered expectations about the potential of 
GWAS in CHD research. In 2013, Cordell et. al. published results on a large GWAS including 
nearly 2000 CHD cases and over 5000 controls23. Despite the large sample size and “careful” 
phenotyping, the authors were unable to reach genome-wide significance in the major CHD 
categories. They detected a suggestive locus associated with the risk for a special type of atrial 
septal defect23. Another similar study in a Han Chinese population found that the risk of atrial 
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septal defects associates with SNP markers near TBX15 and MAML3 [Ref. 24]. Overall, human 
GWAS has had minimal success in identifying causal gene variants. Aside from the weak effects 
of common SNPs, the extreme genetic heterogeneity in human populations reduces the power of 
GWAS. This means that polymorphisms that are associated with risk in one population, are not in 
other populations. As a result, some scientists have decided to limit genetic heterogeneity by using 
animal models to study how genetic variation influences complex traits like CHD. 
 
Using QTL mapping to study complex traits 
 The characteristics that define an individual, e.g. corporal features, physiology and 
temperament can be defined as quantitative traits. A quantitative trait locus (QTL) is a genetic 
region that influences the phenotypic variation in a trait. QTL analysis or mapping is a method that 
uses linkage to nearby genetic markers to identify a locus, or location on a chromosome, containing 
a gene that influences the trait of interest. QTLs are mapped using one of two general methods: (1) 
Linkage mapping and (2) Association mapping. Linkage mapping is typically used to analyze 
small family pedigrees or experimental crosses of divergent inbred animals, where relationships 
between individuals are known. It utilizes recombination events to isolate the genetic markers that 
predict the trait phenotype in an F2 or later generation. This method is effective at detecting loci 
with large effect size using a dozen to a few hundred individuals. Association mapping is similar 
because it also uses recombination, but this method is used for analyzing outbred populations with 
several generations of recombination, such as human or wild organism populations. Myriad 
historical recombination events allow only markers that are closely linked to QTLs to show 
significant association to the trait phenotype. Therefore, association mapping leads to higher 
resolution (much smaller QTL intervals) compared to linkage mapping because of the higher 
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number of recombination events. However, association mapping requires a greater sample size to 
detect QTLs25. An important consideration for any QTL analysis is that it is only possible to map 
QTLs for traits that vary due to genetic differences within a population. 
Early work on QTL analysis took place mainly in agriculture, where people made 
associations between a “neutral” marker phenotype, like color, and a trait of interest. Karl Sax was 
one of the first to study this type of linkage quantitatively when he linked pigmentation pattern to 
seed size in Phaseolus vulgaris, the common bean26. These types of analyses were necessary 
because we lacked neutral, molecular genetic markers that would enable the physical location of 
trait loci. In 1980, David Botstein and his colleagues developed a method to create a genetic 
linkage map using restriction fragment length polymorphisms (RFLPs). A “complete” genetic 
linkage map allowed scientists to use a physical property of the DNA molecule as a marker for its 
physical location on the chromosome27. Nine years later, Botstein collaborated with Eric Lander 
to write a seminal paper proposing the interval mapping method for QTL mapping that makes use 
of a genome-wide RFLP linkage map28. A major strength of interval mapping is its ability to infer 
the presence of a QTL even if it is located between genetic markers. They optimized their method 
for crosses between inbred strains of model organisms, such that the alleles at a marker could take 
one of two possible values. This allowed interval mapping to gain traction rapidly amongst 
experimental biologists and geneticists alike.  
Within a few years, researchers used interval mapping to find QTLs responsible for 
hypertension in rats29,30, type 1 diabetes in mice31, male genitalia shape differences in flies32 and 
more. Investigators even began to use QTL mapping on human data. The link between the APOE4 
allele of the Apolipoprotein E and Alzheimer’s disease susceptibility was identified using QTL 
interval mapping33. This inspired others to try their luck at QTL mapping their favorite human 
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complex trait. Many QTL mapping attempts in humans ended in failure and were attributed to a 
lack of power34. However, the expectation that human data would yield similar results as those 
from inbred model organisms was naïve because human populations are very outbred relative to 
model organisms34,35. This realization spurred the development of SNPs and the GWAS after the 
human genome was finished in 2001.  
When studying complex traits, it is essential to limit the influence of environmental factors 
and control the genetic structure of the experimental populations. Even moderate control of these 
variables is very difficult, if not impossible, in human populations. Therefore, animal models offer 
a distinct advantage over human populations because confounding variables, like genetic structure 
and allele frequency, can be controlled. With animal models, it is possible to address the 
provocative questions in the field of genetics. One of those questions is about the genetic 
architecture of complex traits35,36. How do genetic variants control the expression of complex 
traits? The answer is still unclear, but recent studies are building the foundation needed to 
understand the genetic interactions that regulate complex traits. 
In order to make full use of the genetic code, we must first understand the genetic 
architecture of the phenotypes it encodes. Understanding the complete genetic architecture of even 
one complex trait is far from a trivial task. It requires knowledge of all the genes that underlie a 
phenotype, the portion of those genetic loci that control the trait’s variation, the influence of 
additive, dominance and epistatic genetic interactions, the effects of polymorphisms, environment 
and mutations, the role of pleiotropy, the significance of indirect genetic effects, the role of 
reproductive barriers, and the sum effect of all these factors on the molecular mechanisms that 
determine the quantitative values for the trait37. Although it is not possible to discuss all these 
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components in this format, it is important to realize that every phenotype or trait is the product of 
intricate and interwoven genetic and environmental networks.  
Most of the complex traits that have been studied to date have only addressed a portion of 
the genetic architecture because of the daunting complexity38-44. To simplify the natural 
complexity of these genetic networks, it is essential to limit the scope of search and optimize the 
experimental methods for a specific aspect of the genetic architecture. For example, detecting 
epistatic interactions between QTL requires a large sample size because of the small proportion of 
individuals that will have the double homozygote genotypes. The diminished sample size increases 
the variance of the mean phenotype, which makes interactions more difficult to detect44. Cheverud 
and colleagues found epistatic QTL interactions for mouse litter size by using over 1600 mice in 
their study45. Instead of a brute force approach, using model organisms that enable high-throughput 
methods, such as yeast, can save time and money at the expense of translatability to mammalian 
phenotypes46. Another strategy for detecting epistatic QTL uses congenic strains, namely 
chromosome substitution or genetic introgression lines. These organisms have isogenic 
backgrounds with specific chromosomes or genetic loci “inserted” from another strain, restricting 
the source of phenotypic variation to smaller genetic regions. Spiezio et. al. (2012) demonstrated 
the effectiveness of this approach when they used a chromosome substitution line of mice to detect 
epistatic QTL interactions for dozens of traits while using only a few hundred mice47. Experimental 
designs like this one increase the power to detect QTLs, but they are limited to a subset of the 
important genetic variants available in other populations48. 
Historically, a key weakness of QTL linkage mapping is the lack of mapping precision35,49. 
Many studies used F2 or backcross breeding schemes to generate their study populations, but this 
only allows two or three recombination events per chromosome. As a result, significant QTL 
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intervals typically span several megabases, containing hundreds of genes. It is also possible that a 
QTL with a large effect is actually the sum of two separate QTLs in tight linkage. To address these 
issues, Darvasi and Soller (1995) proposed the use of an experimental population called an 
advanced intercross line (AIL)50. The concept behind the AIL is to take an F2 generation from an 
intercross of two inbred strains and continue randomly intercrossing for several generations 
(Figure 1.2). AILs are a special case of outbred populations because the allele frequencies a start 
0.5 at every marker, which maximizes the power to detect genetic effects of each allele49,50. The 
AIL population will accumulate increasing numbers of recombination events per generation and 
reduce the size of QTL intervals, which permits fine-scale mapping of QTL. A QTL interval 
mapped in an F2 generation will be narrowed by a factor of t/2, where t is the generation number; 
hence, a 30cM QTL interval in the F2, will be 6cM in the F10 [Ref. 50]. As the cost of genotyping 
falls and the density of SNP panels increases, the feasibility and popularity of AILs has surged. 
An important consideration with AILs is population structure. Population structure means 
that there are subpopulations that comprise the whole population49. This is because individuals 
from the same family, i.e. siblings, are more similar genetically. Therefore, there are increased 
correlations between phenotypes within a family because they are closely related (K. Broman, 
Personal Communication, 2014). This will result in an elevated Type 1 Error rate because some 
genotypes will show significant effects only because they are associated with a particular family 
with extreme trait values, not the actual trait per se51,52. Fortunately, association tests that 
incorporate linear mixed models (LMMs) adequately control the false positive rate52. The LMM 
incorporates a random effect, which uses a covariance matrix that accounts for the patterns of 
genetic similarity between all individuals in the population. Freely available LMM software such 
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as GEMMA53 and the R function lmekin54 allow genetic mapping in structured populations in 
human and model organism studies. 
The Cheverud Laboratory was among the first to publish studies that mapped QTLs using 
AILs55. Since the turn of the century, James Cheverud has been breeding an advanced intercross 
of SM/J and LG/J inbred strains. Now his population of LG/J-SM/J advanced intercross (LSAI) is 
at the 56th generation (J. Cheverud, Personal Communication, 2014). The F56 LSAI reduces the 
confidence intervals for mapped QTL to ~1Mb, compared to dozens of megabases in an F2 cross. 
These mice have aided the discovery of genes related to obesity, regeneration, bone length, 
metabolism and responses to trauma56-60. Animal models and quantitative genetics tools, like those 
cited here, enhance our ability to define the genetic interactions that control complex traits and 
diseases alike. Continued work in this field is essential for us to build our understanding of the 
genetic architecture of important traits and develop targeted approaches to modify them. 
 
Animal models of congenital heart disease genetics 
The study of CHD in animals has helped identify numerous genes that are involved in 
normal heart development. Many of the experiments were performed by removing a gene via 
knockouts and studying the resulting cardiac phenotypes61. However, this sort of information does 
not reveal the cause of a majority of CHD cases because most cases lack errors in key CHD 
genes62. The present state of knowledge can be likened to figuring out what makes a car stop 
running by removing random parts. That sort of knowledge is difficult to apply if we need to find 
the faulty part when the car suddenly stops running. Instead, we need to understand both the 
function of each part and be able to recognize suboptimal and broken parts. These concepts apply 
to mechanics and doubly to those studying CHD and heart development. We must develop 
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methods that identify how broken or suboptimal combinations of genes and environments 
influence the risk for CHD. Advances in this area can help shift the field of CHD toward 
preventative interventions. 
Surprisingly, relatively few published studies address how genetic modifiers influence 
CHD risk when a known mutation is present. Some of these published papers address the risk for 
CHD in individuals with Down syndrome (DS). People with DS have a ~50% incidence of CHD63. 
However, since half have normal hearts, it suggests that environmental and genetic modifiers affect 
the CHD risk in this sensitized population. One study found that DS patients with deleterious 
variants of CRELD1 or HEY2 have a significantly higher risk for CHD64. In a DS mouse model, 
they showed that haplo-insufficiency of either modifier increased CHD risk. Another study on DS 
and CHD used genomic rearrangements to show that the genes in a 3.7Mb region on Hsa21 are 
responsible for the elevated risk for CHD65. Therapies that modify the dosage of these genes may 
prove beneficial for individuals with DS or some sporadic cases of CHD. 
 Like the risk of CHD in Down syndrome, mutations in archetypal cardiac transcription 
factors (NKX2-5, GATA4, TBX5, etc.) do not always lead to CHD66-68. Hence, it is sensible to 
consider that there are genetic and environmental modifiers that control the manifestation of CHD. 
For this reason, the Jay Lab decided to search for modifiers of the cardiac master regulator, Nkx2-
5, in a CHD mouse model. Murine cardiac anatomy is very similar to human and is an established 
model for mammalian heart development69,70.  
Winston & Jay et. al. (2010) characterized >3000 Nkx2-5+/- mouse hearts to demonstrate 
that the incidence, types and severity of cardiac defects strongly depended on their genetic 
background71. First, they demonstrated that the pure C57BL/6 genetic background was highly 
susceptible to ventricular (VSD) and atrial (ASD) septal defects in the presence of an Nkx2-5+/- 
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mutation. The incidence of each defect type was near 40%. When Nkx2-5+/- C57BL/6 mice were 
crossed to either an FVB/N or A/J mouse, the incidence of VSDs in their Nkx2-5+/- offspring 
dropped to less than 3%, and ASDs to less than 8%. Relative to Nkx2-5+/- F1 animals, Nkx2-5
+/- F2 
intercross mice of either strain saw a substantial increase in the incidence of both VSDs and ASDs, 
but lower than in the Nkx2-5+/- C57BL/6 background. Interestingly, Nkx2-5+/- C57BL/6×A/J Nkx2-
5+/- F2 had a greater risk of developing ASDs and severe atrioventricular septal defects (AVSDs) 
than the C57BL/6×FVB/N Nkx2-5+/- F2. Primarily, this demonstrates the protective effect of 
heterozygosity on the risk for CHD. Furthermore, these data underscore the effect of polymorphic 
genetic modifiers on CHD risk. A segregation analysis of the C57BL/6×FVB/N crosses suggested 
that at least two polymorphic loci and one epistatic interaction predicted the risk for an ASD or a 
muscular VSD. Even though all the mice in the study are Nkx2-5+/- mutants, their risk for 
developing a heart defect is at least partly dependent on genotypes at other loci.  
In a follow-up study, Jay & his colleagues addressed the genetic architecture of ventricular 
septal defects (VSD) by QTL linkage mapping in the same Nkx2-5+/- mouse model72. They mapped 
significant QTL for membranous and muscular types of VSDs in the Nkx2-5+/- F2 offspring of an 
Nkx2-5+/- C57BL/6×FVB/N F1intercross. Remarkably, the risk for VSDs in the Nkx2-5
+/- offspring 
increases incrementally each month as the mother ages. This maternal age-associated risk for CHD 
was not explained by aneuploidy. This finding supports Nora’s prediction that multifactorial 
influences control the risk for CHD7. It also recapitulates epidemiological data that implicate 
maternal age as a CHD risk factor in humans73,74. 
The Jay Lab continued to explore the maternal age-associated risk factor in their most 
recent publication75. Prior to this study, it was not known whether the maternal age risk came from 
old ovaries or factors within an aged mother. To address this, they performed reciprocal ovary 
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transplants between young (< 100 days) and old (>300 days) C57BL/6 mothers and assessed the 
incidence of CHDs in the Nkx2-5+/- offspring (Figure 1.4). The results determined that an increased 
incidence of VSDs tracked with old mothers with young ovaries; young mothers with old ovaries 
maintained a baseline incidence of defects. An analysis of different maternal strains revealed that 
the presence and extent of the maternal age-associated risk varied by genetic background. Another 
set of experiments showed that the maternal age effect was not simply due to obesity or insulin 
resistance in old mothers. Most importantly, they discovered that mice mothers that exercised ad 
libitum were able to eliminate the increased risk of CHD in their Nkx2-5+/- offspring. 
There are a few conclusions to draw from this study. First, the results indicate that there 
are maternal genetic and environmental mechanisms that can meaningfully modify the risk for 
cardiac defects in predisposed offspring. Because the maternal age risk followed old mothers, it is 
likely that physiological changes, in response to exercise, restore facets of a youth-like state in the 
old mothers. The maternal age risk was absent in some strains and pronounced in others, implying 
a maternal-fetal gene × gene interaction that can be modified by the maternal behaviors and 
environment. The fetal risk for CHD is high due to an Nkx2-5+/- mutation, but that risk may be 
elevated because of the mother’s genetic susceptibility to age-related physiological changes. Since 
the magnitude of the age-related risk is different across mouse strains, there must be maternal 
genes that regulate this effect. Therefore, we can use these strain-specific differences to map these 
genes and identify the responsible molecular pathways. 
Maternal-fetal interactions, like the maternal age-associated risk of CHD, prove that the 
genetic architecture of CHD is quite complicated, but this is likely true of all complex traits. 
Indirect effects are an important, yet underappreciated, aspect of genetic architecture76,77. Maternal 
effects are a type of indirect genetic effect where the mother contributes to the phenotypic variation 
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of traits in the offspring through mechanisms that are independent of inherited maternal genes78. 
In order to construct a trait’s genetic architecture, it is important to determine the extent of trait 
heritability. Heritability specifies the extent of correlation between the individual’s genes and the 
expressed trait. Failure to account for indirect effects can lead to inflated heritability estimates, 
meaning that estimates of QTL effects may be overestimated79. Maternal effects are inherently 
difficult to estimate because they are confounded by the 50% genetic similarity between mother 
and offspring80. Confounding, in this respect, can lead to a correlation between maternal phenotype 
and offspring phenotype for the same trait, which can be erroneously attributed solely to genetic 
inheritance. 
In the case of the maternal age-associated risk of CHD, maternal genetic effects are most 
relevant because environment is uniform and paternal age is not a risk factor72. The age-associated 
risk for CHD is not purely a maternal genetic phenotype because its effects are also a function of 
maternal age. Therefore, this trait will only exist when a mother has the combination of genetic 
polymorphisms that make her susceptible to the ageing effect and the offspring has a genetic 
predisposition to CHD. It is unlikely that there will be confounding between the effects of maternal 
genotype and offspring genotype because they control different traits. QTL mapping experiments 
designed to identify the maternal genetic pathways that control the age-associated risk for CHD 
hold significant promise because the risk is modifiable by exercise. Therapies directed at the 
mother to target deficiencies in the offspring are particularly attractive because they avoid the 
perilous hurdles of in utero interventions. For this to be possible, we must develop a better 
understanding of how maternal genetics and environment interact to influence fetal cardiac 




Goals of the Thesis 
One interesting feature of congenital heart disease, and other genetic diseases, is that 
strikingly different phenotypes can result from one, ostensibly Mendelian, mutation. NKX2-5 
mutations elicit a range of incompletely penetrant heart defects that vary in anatomic location and 
severity. This suggests that interactions between a mutation and other factors, environmental or 
genetic, determine the phenotypic outcome. The first aim of my thesis is to dissect the genetic 
architecture of phenotypic variability in CHD through animal models. Our mouse model replicates 
CHD risk in susceptible people through a heterozygous mutation in Nkx2-5, an essential cardiac 
transcription factor. We used inbred strain crosses and quantitative genetic methods to identify 
genetic polymorphisms that modify CHD risk in Nkx2-5, haploinsufficient mice. I then assessed 
how epistatic interactions between genetic modifiers of Nkx2-5 influence the CHD phenotype that 
occurs. 
The second goal of my thesis stems from the brilliant discovery that maternal age increases 
the offspring CHD risk, both in humans and in our Nkx2-5 mouse model. Prior studies in the Jay 
laboratory showed that this risk is due to factors within aging mouse mothers, not old ovaries. 
Further, voluntary exercise is sufficient to reduce her CHD risk to baseline levels. These 
experiments showed that the maternal age risk varied according to the genetic background of the 
mice, indicating that it is a quantitative genetic trait. The second aim of my thesis is to identify 
genes that influence the variation in the maternal age effect. We partnered with the laboratory of 
James Cheverud to use a 56th generation, advanced intercross mouse population to identify CHD 
modifier loci to nearly single-gene resolution. The mapping analysis requires developing models 






Figure 1.1  The causes of congenital heart disease 
Nearly two-thirds of all CHD cases are unexplained. Most of the cases with a known cause are 
the result of de novo CNVs and gene mutations. Inherited mutations are still expected to play a 





Figure 1.2  Advanced intercross chromosomes 
After several generations of random intercrossing, advanced intercross chromosomes have 





Figure 1.3  Coronal section of a wildtype mouse heart 
This histological section shows all 4 heart chambers. The anatomical structure is nearly identical 
to the human heart. The areas with slight differences are located around the venous pole of the 
heart. The human heart has 4 pulmonary veins that enter the left atrium, while the mouse has the 
pulmonary veins join together before abutting the left atrium81.  Ao, Aorta; RA, LA, right, left 





Figure 1.4  Reciprocal ovary transplants between young and old mice shows that the maternal 
age effect is a function of old mothers, not old eggs 
Panel A) shows a schematic for the ovary transplant surgeries and the sample sizes used. B) Old 
mothers with young ovaries have more than twice the incidence of VSDs compared to young 







Table 1.1  Congenital heart disease-associated genes 
These 334 genes were compiled from Zaidi et al. 2013 and Li et al. 2015 (Refs. 82 and 83). 
 
Acan BMPR2 Dnm2 GJA9 LEFTY2 NKX3-2 PTPN11 TBX20 
ACP6 BUB1B DOLK Gm572 LEMD3 NODAL RAB10 TBX3 
ACTA2 C1orf106 DPPA4 GPC3 LLPH NOTCH1 RAB23 TBX5 
ACTC1 Cc2d2a DQ983818 GPR161 Lox NOTCH2 RAI1 TCF21 
ACVR1 Ccdc151 Drc1 GPRC6A LPIN1 NOTCH2NL RAI2 TDGF1 
ACVR2B CCDC39 DVL1 GSK3B Lrp1 NOTCH3 RAPGEF5 TFAP2B 
Adamts6 CCDC40 DVL2 HAND1 Lrp2 NOTCH4 REL TGFBR2 
AHSA2 CCT4 Dync2h1 HAND2 LRRC50 NOTO RFX2 TLL1 
AKAP9 CDH2 Dyx1c1 Hectd1 LRRC6 NPHP3 RFX3 TMBIM4 
ANKRD1 Cep110 DZIP1 HES1 Ltbp1 NPPA Robo1 TMEM195 
Anks6 Cep290 EED HES4 MARK2 NSD1 ROCK2 Tmem67 
Ap1b1 CER1 EHMT1 HEY2 MAX NUMBL ROR2 TNFRSF21 
Ap2b1 CFC1 ELN HOXA1 MED13L NUP188 ROTATIN TSC1 
APOBEC2 Cfc1 EP300 ID2 MEF2A OFD1 RPGRIP1L TSEN15 
ARL13B CHD1L ESCO2 IER2 MEF2C OSR1 RUNX2 TTC21B 
Armc4 CHRAC1 EVC IFT122 Megf8 PAPOLG S100Z TTC30A 
ASXL2 CHRD EVC2 Ift140 METT10D PCMTD2 SALL1 TWIST1 
ATE1 CITED2 EZH1 IFT172 MGAT1 PCNT SALL4 TXNDC3 
ATP1A2 CLDN7 FBN1 IFT20 MGP PCSK5 SDC2 UBR1 
ATP4A CLUL1 FBN2 IFT57 MID1 Pcsk5 SEMA3E USP34 
ATP4B Cml5 FGF8 Ift74 MKKS Pde2a SESN1 VANGL2 
BBS1 CREBBP FGFR1 IFT88 MKS1 PEX1 SHH VEGFA 
BBS10 CRELD1 FIBP1 IGFBP4 Mmp21 PEX13 SHOC2 VEGFC 
BBS11 CRHBP FLNA IGFBP5 MNDA PHYHD1 SIL VIT 
BBS12 CRX FMO5 IHH MSX1 PIFO SLC2A10 WNT3A 
BBS2 CSRP1 FOXA2 INVERSIN MSX2 PITX2 SMAD2 XPO1 
BBS3 CTNNA3 FOXC1 IPPK MYH10 Pkd1 SMAD5 ZAC1 
BBS4 Cxcr4 FOXH1 ISL1 Myh10 PKD1L1 Smad6 Zbtb14 
BBS5 DAND5 FOXJ1 JAG1 MYH11 Pkd1l1 Smarca4 ZEB2 
BBS6 Daw1 FOXL2 JAZF1 MYH6 PKD2 SMARCD3 ZFPM1 
BBS7 Dctn5 Frem2 JBTS17 Ndst1 PLAGL1 SMO ZIC3 
BBS8 DHCR7 FTO KCNE1 NEK2 Plxnd1 SNAI1 ZNF480 
BBS9 DLL1 Fuz KCNJ2 Nek8 PPM1K Snx17 ZNF528 
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BCL11A DMRT2 GADL1 KCNQ1 NF1 PPP3CA SOS1 ZNF534 
BCL6 Dnaaf3 GALNT11 KIAA1841 NFATC1 PQPB1 SOX17 ZNF610 
BCL9 Dnah11 GATA4 KIF3A NFATC3 Prdm1 SRF ZNF638 
BCOR DNAH2 GATA5 KIF3B NFATC4 Prickle1 STIL ZNHIT3 
BICC1 DNAH5 GATA6 KIF3C NIPBL PRKAB2 SUFU  
Bicc1 Dnah5 GDF1 Kif7 NKD1 PROX1 Sufu  
BMP4 DNAI1 GJA1 KIFAP3 NKX2-5 Pskh1 SUPT3H  
BMP7 Dnai1 GJA5 KLF13 NKX2-6 PTCH1 Tab1  
BMPR1A DNAI2 GJA8 LBR  PTCH2 Tbc1d32  
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Congenital heart disease (CHD) is recognized as the most common birth defect, but it 
actually encompasses multiple, anatomically distinct phenotypes. The types of heart defects show 
an inverse relationship between their severity and incidence. For example, secundum atrial septal 
defects (ASDs), which are compatible with survival into middle age, are three times more common 
than atrioventricular septal defects (AVSD), which can cause death during infancy1,2. The inverse 
relationship has no simple explanation, such as by the relative frequencies of the causes of mild 
and severe defects. The relationship does imply, however, that each defect has a liability threshold 
related to its severity. The higher the threshold, the rarer a defect is. The developmental pathways 
that are affected in a severe defect must be more robust to perturbation than the pathways involved 
in a mild defect. 
CHD could thus be a compelling model to examine the connections between the fitness 
cost and genetic architecture of a phenotype. As a rule, the same deleterious mutation can manifest 
as a mild, moderate or severe defect in different individuals. Modifier genes affect the phenotypic 
outcome3. Genetic heterogeneity and rare alleles hinder their characterization in humans, but 
inbred strain crosses in mutant mouse models can circumvent these limitations. The number of 
alleles at a locus can be limited to two, and the frequencies of both alleles can be kept equally 
common. We have shown through such crosses that the incidence of particular defects in Nkx2-
5+/- mice varies between genetic backgrounds. NKX2-5 mutation causes non-syndromic CHD in 
humans4,5. Genetic interactions modulate the susceptibility of the cardiac developmental pathways 
to a deleterious mutation6,7. In addition, first-generation (F1) hybrids of the inbred strains 
C57BL/6N and FVB/N or A/J have a lower incidence of heart defects than Nkx2-5+/- mice in the 
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C57BL/6N background or the second-generation (F2) offspring of backcrosses to the parental 
strains or intercrosses (F1×F1). The observations suggest hybrid vigor; that is, genome-wide 
heterozygosity increases the average robustness of a population6. 
The observations also suggest that variation in the robustness to the Nkx2-5 mutation – and 
conversely the liability to a heart defect – results from variation in the effects of genetic 
interactions. Epistasis contributes quantifiably to the variation of fitness traits in simple organisms, 
such as yeast8, Drosophila9 and C. elegans10. On the other hand, statistical genetic evidence from 
higher organisms, such as mice or humans, is scant, and theoretical analyses arrive at disparate 
conclusions regarding the significance of epistasis in complex traits or disease11,12. The reasons 
why the results conflict is hotly debated13. One, less commonly discussed reason is that the 
contribution of epistasis could vary with the fitness cost of a phenotype12. Selection indisputably 
eliminates deleterious mutations, but selection may also increase the robustness of pathways to 
perturbation by shaping genetic interactions and networks14. We thus reasoned that a comparative 
analysis of the genetic architecture of four CHD phenotypes under the same mutation could offer 
insight into the problem. The four defects – ASDs, muscular and membranous ventricular septal 
defects (VSD), and AVSD – have fitness costs that range from mild to severe, as defined by the 
likelihood of survival to reproductive age in humans. We determined the number and effects of 
quantitative trait loci (QTLs) on the risk of each heart defect in Nkx2-5+/- mice from two different 
inbred strain crosses. Each QTL represents a pairwise interaction between a modifier gene and 
Nkx2-5 (G×GNkx). In addition, we examined the effects of higher-order interactions between two 
QTLs and Nkx2-5 (G×G×GNkx). Empirical data are sorely needed to understand the nature of 
genetic risk in CHD. More fundamentally, a quantitative analysis of epistasis in a set of mutant 
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We phenotyped ~10,000 Nkx2-5+/- newborns from intercrosses between the inbred strains 
A/J and C57BL/6N (A×B, N = 2999) and FVB/N and C57BL/6N (F×B; N = 6958). An ASD is 
the most common diagnosis associated with human NKX2-5 mutation5,16. An ASD is also most 
common in the mouse crosses, followed by membranous and muscular ventricular septal defects 
(VSD) and AVSD (Figure 2.1A). The two anatomic types of VSD have different developmental 
bases, but similar pathological consequences. We note this because epidemiological data generally 
count membranous and muscular VSDs together, making VSD appear more common than ASD1. 
Both intercrosses recapitulate the epidemiological relationship between the severity and incidence 
of a heart defect (Figure 2.1B). The attrition of more severely affected embryos does not explain 
the distribution of defects because Nkx2-5+/- mice are born at the expected Mendelian ratio6. In 
fact, very severe defects, such as double outlet right ventricle and tricuspid atresia, were observed, 
but there were too few for quantitative genetic analysis. About 70% of Nkx2-5+/- mice from either 
intercross have a normal heart, implying that the mutation is modestly deleterious overall. 
The total effect of genetic modifiers on quantitative risk could be a function of the number 
of genes, their effect sizes or both. To distinguish these possibilities, we mapped the modifiers in 
the F2 intercross of A×B and in the combined F2 and advanced intercross generations of F×B 
(Figure 2.2). Mapping in an F2 intercross has greater power to detect loci, whereas the combined 
analysis of an F2 and later generations has greater mapping resolution17. We identified QTLs for 
ASD, membranous and muscular VSD, and AVSD (Fig. 2.3A, Table 2.1). Each set of QTLs 
represents G×GNkx interactions in developmental pathways leading to a defect. QTLs that overlap 
between defects may share a gene involved in the development of multiple cardiac structures. 
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The number of detected loci is similar between the four heart defects (Figure 2.4A). G×GNkx 
effect sizes, however, vary with the severity of a defect. G×GNkx interactions have a small effect 
on ASD risk and increasingly larger effects for VSDs and AVSD. The correlation holds whether 
the effect is calculated as the risk associated with a susceptibility allele or the phenotypic variance 
explained by a locus (Figure 2.3B, C). To account for undetected loci, we estimated the phenotypic 
variability explained by all genotyped SNPs. The heritability is similar between defects (Figure 
2.4B). The correlation between G×GNkx effect size and severity is not due to a larger total genetic 
contribution to the risk of severe defects. 
While each locus was mapped according to its individual effect on risk, two loci may 
interact. Representative examples compare the observed defect incidences at two-locus genotypes 
to the expected incidences under the null model of non-interacting loci18. Small differences 
between the observed and expected incidences of ASD and VSD indicate that each locus exerts 
mainly independent or additive effects (Figure 2.5A, B; Figure 2.6). In contrast, the incidence of 
AVSD at a two-locus genotype can deviate substantially from the null expectation, indicating a 
non-linear effect. Some differences are especially large relative to the population or the 
unweighted average incidence of a defect across the nine genotypes (Figure 2.5C, D; Figure 2.6). 
The latter calculation of incidence permits comparisons between defects of higher-order epistatic 
effects independently of genotype frequencies. The population and unweighted average incidences 
are correlated in the inbred strain crosses because there are only two common alleles per locus. In 




Similar to G×GNkx interactions, G×G×GNkx effect sizes increase with the severity of a defect 
(Figure 2.5E). We calculated the G×G×GNkx contribution to the observed incidence of a defect at 
each of the nine genotypes between every pair of significant and suggestive loci (or the next most 
significant locus in the two cases where there is just one suggestive locus). Statistically significant 
G×G×GNkx effect sizes vary between defects. AVSD effects are larger than ASD and VSD effects. 
The relationship is not secondary to an underlying correlation, such as between the observed 
incidence at a two-locus genotype and the G×G×GNkx effect size or the severity of a defect. 
Patterns of G×G×GNkx effects suggest that, during the inbreeding of mouse strains, fitness 
pressures positively selected genotypes, resulting in the coadaptation of interacting genes, as 
opposed to the elimination of intrinsically deleterious alleles. Among significant G×G×GNkx 
effects, two-locus genotypes that are homozygous at both loci for alleles from the same inbred 
strain or “syn-homozygous”, e.g., BB at both loci, are more likely to lower risk. Conversely, anti-
homozygous G×G×GNkx effects, e.g., homozygous FF at one locus and BB at the other, are more 
likely to raise risk. Heterozygosity at either locus is equally likely to raise or lower risk (Figure 
2.7A). Syn- and anti-homozygous G×G×GNkx interactions can have major effects on the risk of a 
severe defect. For example, one anti-homozygous, two-locus genotype accounts for 50% of all the 
AVSDs in the F×B intercross (Figure 2.5D). The genotypes at either locus are not intrinsically 
deleterious because Nkx2-5 wild-type mice, including littermates of affected mutants, do not 
develop AVSDs. Conversely, both syn-homozygous genotypes at two loci in the A×B intercross 
effectively suppress AVSD risk (Figure 2.5C). In general, no one- or two-locus genotype skews 
ASD or VSD risk as extremely (Figure 2.6). 
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Selection for coadapted genotypes likely increased the robustness of cardiac developmental 
pathways to subsequent perturbations – Nkx2-5 mutation in this case. Internally consistent 
G×G×GNkx effects further suggest that selection for coadaptation was a recurrent event in each of 
the inbred strains examined. Protective and deleterious effects of syn- and anti-homozygosity, 
respectively, are associated with congruent effects at the other syn- and anti-homozygous 






Normal cardiac development is crucial for survival to reproductive age, but CHD 
phenotypes exact widely ranging costs on fitness with severe defects being rarer than mild ones. 
One must wonder whether there is an evolutionary basis for these observations19. Highly penetrant, 
mostly de novo genetic abnormalities account for about one third of all CHD cases3, but they do 
not obviously account for the inverse relationship between defect severity and incidence. For 
example, ASDs represented more than 10% of CHD cases in two large, whole-exome sequencing 
studies20,21. The present results suggest instead that the inverse relationship is a consequence of 
the genetic architectures of individual phenotypes. The results offer novel insights into the nature 
of genetic risk in CHD and the origins of mutational robustness. 
Genetic heterogeneity and rare alleles obscure the biological significance of epistasis in 
human diseases. In contrast, inbred strain crosses offer more power to detect genetic interactions 
in the setting of naturally occurring variation. Through such crosses, we show that the effects of 
pairwise and higher-order epistasis correlate with the severity of a heart defect in Nkx2-5+/- mice. 
Other features of the genetic architecture of a defect, such as the number of QTLs, do not correlate. 
The QTLs for mild ASDs exert mainly small, additive effects on risk, while the QTLs for severe 
AVSDs exert large, additive and non-linear effects. The QTLs for moderately severe, ventricular 
septal defects have intermediate effects. Strikingly non-linear G×G×GNkx effects at certain two-
locus genotypes can effectively suppress the risk of an AVSD or account for a large fraction of 
AVSDs in the Nkx2-5+/- population. These observations support a complex genetic model for the 
inverse relationship between the severity and incidence of a defect in humans. Whereas a modestly 
deleterious mutation may be sufficient to cause a mild defect, additional interactions with other 
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loci are necessary to surpass the liability threshold for a severe defect. Severe defects are hence 
rarer because the relevant multi-locus genotypes are improbable. Consistent with this model, a 
small study of non-syndromic AVSD found that among 34 persons who carried a mutation of one 
of six AVSD genes, NIPBL, CHD7, CEP152, BMPR1A, ZFPM2, or MDM4, 8 carried two or more, 
rare or rare, damaging nonsynonymous variants of the six genes. Larger studies are necessary to 
confirm the result and validate the potential interactions22.  
The model further suggests a corollary for strongly deleterious mutations. Epistasis should 
matter less because the mutations place individuals near or beyond the liability threshold for a 
defect. To exert the same phenotypic effect as a weak mutation and its associated genetic 
interactions, a strong mutation must either obstruct one critical pathway or perturb several 
simultaneously. The dramatic effect of de novo mutations of histone-modifying genes, which 
regulate the expression of multiple developmental genes, is consistent with the latter possibility23. 
Although genome-wide heterozygosity is associated with an overall lower risk of CHD in 
Nkx2-5+/- mice, which indicates hybrid vigor, the effects of syn- and anti-homozygosity at 
interacting loci suggest genetic coadaptation. Dobzhansky introduced the concept of selection for 
alleles in gene complexes by virtue of the fitness benefits that their interaction confers in 1948 
[Refs. 24,25]. Coadapted genes are probably widespread but under-detected because the alleles at 
either locus are not intrinsically deleterious. Recent examples relate to growth under different 
conditions in yeast8, male fertility in Drosophila9, body composition phenotypes in mice26, and 
vitamin D receptor and skin color gene coadaptation in humans27. An especially elegant example 
demonstrates genetic coadaptation in the regulation of fasting plasma glucose levels, a diabetes-
related trait. In a set of mouse crosses involving chromosomal substitution strains, one or two, 
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different chromosomes from the A/J strain were introduced into the C57BL/6J background. Five 
interactions were discovered between pairs of A/J chromosomes that promoted normal glucose 
homeostasis. Compared to the control, C57BL/6J strain, mice that carried either A/J chromosome 
of an interacting pair had elevated glucose levels. Yet, the levels fell back to normal when mice 
carried both A/J chromosomes rather than rise higher as an additive model would predict28. A/J 
and C57BL/6J appear to have arrived at different genetic solutions to maintain normal plasma 
glucose levels, just as the three strains in the present work must promote the robustness of cardiac 
developmental pathways. 
Finally, whether robustness to mutation arises by selection or as an inherent consequence 
of an adapted trait has been a longstanding debate14,29.  The results thus offer a rare example of 
selection for genetic robustness15. Depending upon the experimental design, investigators have 
lacked either the ancestral population to assess the pre-robust state or the years required to detect 
selection for robustness in an evolving population14. Our application of inbred strains, which were 
selected for fitness under genome-wide homozygosity, addresses these challenges. Unknown 
pressures appear to have selected strain-specific genotypes at interacting loci that enhance the 
robustness of cardiac developmental pathways to subsequent perturbation. Nkx2-5 mutation was 
probably not the original selection pressure because there are many potential causes of CHD. 
Nevertheless, outbreeding in our intercrosses produces individual variation in the robustness to 
Nkx2-5 mutation. Modifier locus genotypes permit us to observe the analog of pre- and post-
selected states in the same population. If humans likewise vary in robustness, then the genetic basis 
of CHD is a function not only of deleterious variants but also of the degree of coadaptation of 




Mouse strains and crosses 
Inbred C57BL/6N (B) and FVB/N (F) mice were purchased from Charles River 
(Wilmington, Massachusetts) and A/J (A) from the Jackson Laboratory (Bar Harbor, Maine). The 
Nkx2-5+/- mutant line is maintained in the C57BL/6N background 6,30. To produce F1 hybrids, 
Nkx2-5+/- C57BL/6N males were crossed to wildtype A/J or FVB/N females. The Nkx2-5+/- F1 was 
then crossed to produce A×B and F×B F2 progeny. We also produced F10 and F14 advanced 
intercross generations of F×B by random mating from the F2 generation onward. Mating between 
siblings and first cousins was avoided from the F3 and F4 generations onward 
31. Mice were housed 
under standard conditions in the same room with access to water and chow ad libitum. The 
Washington University School of Medicine Animal Studies Committee approved the experiments. 
 
Heart collection and phenotyping  
We collected and phenotyped hearts as previously described 6. Briefly, pups were collected 
within hours of birth. Thoraxes were fixed in 10% neutral buffered formalin. After Nkx2-5 
genotyping, all Nkx2-5+/- and a subset of wild-type hearts were dissected and embedded in paraffin. 
Hearts were completely sectioned in the frontal plane at 6 µm thickness. Every section was 
collected, stained with hematoxylin and eosin, and evaluated by two individuals. All defects were 
diagnosed by the morphology of the atrial and ventricular septae, semilunar and atrioventricular 
valves, chambers and the anatomic relationships between them. Secundum ASDs were 




Single nucleotide polymorphism genotyping 
Genomic DNA was isolated from tissues by phenol-chloroform extraction. Single 
nucleotide polymorphism (SNP) genotyping was performed on a subset of the phenotyped animals. 
Samples were selected to maximize the number of mice with heart defects while maintaining a 
comparable number of control mice. Control mice had normal hearts and were selected semi-
randomly in the AILs to avoid over-representation of individuals from low-incidence families.  For 
the heart defect cases, we SNP genotyped mice with the largest sized defects relative to anatomical 
landmarks in each heart. See Table 1 for the sample sizes of SNP genotyped mice per population. 
For the A×B6N and FVB×B6N F2 crosses, we created custom SNP panels on the Sequenom 
MassARRAY system6. We ascertained 102 and 129 SNPs evenly distributed across all 19 
autosomes from the A×B6N and FVB×B6N F2 crosses, respectively. The average marker density 
ranged from 19-24 Mbp. The X chromosome was not included in this study because preliminary 
studies did not show any suggestive loci on the X chromosome. 
Mice from the FVB×B6N F10 and F14 AIL populations were genotyped using the Illumina 
Mouse MD Linkage Panel. 1359 SNPs were ascertained across all autosomes. We used the UCSC 
Genome Browser (genome.ucsc.edu) to update the SNP identifiers and locations to the 
GRCm38/mm10 (Dec. 2011) mouse genome build. We removed 4 SNPs that were not found in 
dbSNP (build 141). We removed SNPs with > 10% missing or with low median quality scores 
(GC < 0.35), and removing SNPs that are not polymorphic between B6N and FVB strains. After 
QC, 761 SNPs remained. The genotype data from the FVB×B6N F2 and AIL crosses were 
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combined and 3 markers were genotyped in all crosses, leaving a total of 887 markers with an 
average marker density of 3 Mbp. Appendix I provides the full list of SNPs. 
 
Genotype probabilities and imputation 
To increase the mapping resolution and enhance power17, we combined the F2 and AILs 
from the FVB×B6N mouse crosses. This required imputing the SNPs that were not ascertained in 
the alternate mouse population.  
In the F2 mice, we used R/qtl
30 (version 1.40-8) to calculate the genotype probabilities of 
758 SNPs that were ascertained only in the AIL mice30. For the missing genotypes in the AILs, we 
used QTLRel31 (version 0.2-15) to calculate the genotype probabilities of 126 SNPs that were only 
ascertained in the F2 mice. The genotype probabilities calculated by QTLRel account for the 
recombination patterns based on the AIL generation, therefore we calculated the genotype 
probabilities separately for the F10 and F14 crosses. The genotype probability data from all three 
crosses was combined and then converted to imputed allele dosages or posterior mean genotypes 
in the BIMBAM genotype file format [see GEMMA32 manual, 
http://www.xzlab.org/software/GEMMAmanual.pdf]. The BIMBAM genotype file uses genotype 
probabilities during association testing to account for uncertainty in the imputed genotypes. 
We imputed missing genotypes for each locus that was used in the epistatic effect analyses. 
For the F2 populations, we used R/qtl to impute all missing genotypes to that with the maximum 
marginal probability. With this process, 80% of missing genotypes were imputed with > 70% 
confidence; only 2% of missing genotypes were imputed with less than 50% confidence. For the 
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AIL population, we used QTLRel to impute the missing genotypes separately for the F10 and F14 
crosses. 99.9% of missing AIL genotypes were imputed with > 70% confidence. 
 
Genetic mapping 
We performed case-control genome-wide association tests separately for each of the 4 heart 
defects: atrial septal defects, membranous ventricular septal defects, muscular ventricular septal 
defects, and atrioventricular septal defects. Although we found other rare and severe heart defects, 
like double outlet right ventricle, their sample sizes (< 20) were insufficient for genetic analyses. 
Mapping in the combined FVB×B6N F2 and AIL mice crosses required special 
considerations, as discussed in Parker et al. 2014 [Ref. 17]. The main issue is unequal relatedness 
between individuals in the AIL populations, which leads to elevated false-positive rates if not 
properly controlled. To account for relatedness, we used the univariate linear mixed model 
implemented in the GEMMA32 (version 0.94.1). We modeled specific heart defects as binary 
phenotypes using genome-wide SNPs and a “random” or “polygenic” effect that accounts for 
relatedness: 
𝑦 = 𝜇 +  𝑥𝛽 + 𝑢 + 𝜖; 
where y is a vector of binary phenotypes (0 = control, 1 = heart defect), μ is the mean, x is 
a vector of SNP marker genotypes, β is a vector of marker effects, u is a vector of random effects, 
and ϵ is a vector of errors. 
Linear mixed models account for relatedness by including a genetic covariance or 
relatedness matrix (GRM), which captures the variance in the phenotype that is due to the genome-
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wide similarity between individuals. For each case-control analysis, we used GEMMA to estimate 
centered GRMs using the SNP genotypes from the combined F2 and AIL FVB×B6N population. 
However, we found that there was little power to detect genetic associations.  This was because 
the average pairwise relatedness between F2 mice was estimated to be near 0, which suggests they 
are unrelated. Because all F2 individuals are effectively full-siblings and share on average 50% of 
their genotypes, we substituted the F2 - F2 relatedness coefficients in the GRM with 0.5, the 
expected value for a full sibship, and 1 on the diagonal. This substitution allowed us to dramatically 
improve our power to detect genetic associations in the combined F2 and AIL population. F2-AIL 
relatedness coefficients were not changed. Then we adjusted the entire matrix (F2 + AIL) to the 
nearest positive definite matrix using the nearPD function in the “Matrix” R package (version 1.2-
6). This adjustment adds a small amount of noise to the GRM to remove negative eigenvalues, 
which is necessary for stability of the mixed model. A Mantel test for similarity between the pre- 
and post-adjusted GRMs showed > 95% similarity in all cases. 
In the combined FVB×B6N F2 and AIL, we used the likelihood ratio test in GEMMA to 
test the alternative hypothesis that a SNP has a non-zero effect against the null hypothesis that is 
has zero effect. We set genome-wide significance thresholds by Bonferroni-correction. The 
number of tests for the correction was calculated with the simpleM software33, which estimates 
the effective number of independent tests by accounting for linkage between SNP markers. The 
number of effective tests or markers was 542. Therefore, significant loci had P values < 9.2×10-4 
(0.05/542) and suggestive loci had P values < 1.8×10-3 (1/542)34. 
We performed interval mapping separately for each heart defect in the A×B6N F2 
population using the binary trait model in R/qtl. We calculated genotype probabilities at missing 
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genotypes and 9cM intervals. Statistical significance was determined by 5000 permutations. 
Significant loci (α = 0.05) had LOD scores > 3.3, and suggestive loci (α = 0.20) had LOD scores 
> 2.7 [Ref. 34].  
 
Estimation of heritability 
The percent phenotypic variance explained by all genotyped SNP that interact with Nkx2-
5+/- (genome-wide PVE) can be estimated using restricted maximum likelihood (REML) in the 
linear mixed model in GEMMA. This method uses the GRM to estimate the genome-wide PVE 
and its standard error in each case-control population. In the absence of Nkx2-5 mutation, this 
method would be similar to estimating the narrow-sense heritability (h2) from genotyped SNPs. 
We used GEMMA to estimate the GRMs for the A×B6N F2 population and used the same matrices 
used for mapping the combined FVB×B6N population.  
We corrected the PVE estimates for ascertainment and transformed them to the liability 




where P is the population disease incidence, A is incidence in the ascertained cohort, and z is the 
height of the standard normal distribution at the population liability threshold36. Our genome-wide 
PVE estimates may slightly underestimate the true PVE because we did not include the sex 





Analysis of G×GNkx effects 
We estimated the percent variance explained by each modifier SNP (SNP PVE) using the 
equation: 
[(MAF × (1 − MAF)) × β2]
Phenotype Variance
; 
where MAF is the SNP minor allele frequency and β is the effect of the SNP in a linear 
model. The SNP PVE estimates were corrected and transformed to the liability scale in the same 
manner as the genome-wide PVE estimates. We used GEMMA to estimate βs for FVB×B6N SNPs 
using the GRMs from the mapping procedure. The effects of A×B6N SNPs were also estimated in 
GEMMA while using a GRM with all individuals set as full-siblings (relatedness coefficients set 
to 0.5). 
We estimated odds ratios for the G×GNkx effects using logistic regression models. Odds 
ratios for each locus identified in the A×B6N F2 population were obtained using the base glm 
function in R. Odds ratios for each locus identified in the combined FVB×B6N population were 
obtained using the logistic mixed model implemented in GMMAT37. This mixed model allows us 
to control for relatedness in the AIL using the same relatedness matrices that were used in the 
mapping procedure. 
 
Analysis of G×G×GNkx effects 
Third-order epistais effects (G×G×GNkx), between two modifier loci and Nkx2-5
+/-, can be 
estimated from the pairwise interactions between modifiers. Therefore, we quantified the 
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contribution of G×G×GNkx epistasis to the observed risk for each two-locus genotype using 
Cheverud & Routman’s physiological epistasis model18, which is not weighted by allele 
frequencies. Two-locus genotype refers to one of the nine possible genotypic combinations 
between interacting modifier loci (see Figure 2.5). In short, we computed epistatic effects as the 
difference between the observed defect incidence and the expected incidence in the absence of 
G×G×GNkx epistasis. The expected incidence is estimated from the two modifier loci by assuming 
they affect risk independently. This expected incidence can be calculated as the unweighted 
regression of the two-locus genotype incidences onto the two single-locus incidences. The epistatic 
effects are measured in units of heart defect incidence, with the sign depending on whether the 
epistatic effect enhances (+) or suppresses (-) incidence at that two-locus genotype. To identify the 
significant epistatic effects, we arcsine-transformed the data to obtain unbiased variances as 
described by Sokal & Rohlf38. Using these variances, we conducted two-tailed T-tests to determine 
which epistatic effects were significantly different from zero. The P value threshold for the T-test 
was a Bonferroni-corrected 0.05 significance threshold. The number of tests was equal to the 
number of pairwise combinations of loci multiplied by nine, the number of two-locus genotypes.  
Significant epistatic effects were rescaled by dividing by the unweighted population 
incidence, which is the arithmetic mean of the nine incidences at each two-locus interaction18. 
These rescaled epistatic effects show the change in observed risk as a percentage of the defect’s 
population incidence. This allowed us to compare the relative magnitudes of the epistatic effects 
even though the heart defect incidences are different. Custom R code was developed to perform 
this analysis. Because we only identified one G×GNkx modifier locus for ASD and Mus. VSD in 
the FVB×B6N population, we assessed G×G×GNkx effects in combination with the next most 
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significant locus; ASD: rs13478997, Chr. 6, 55cM, P = 1.94×10-3; Mus. VSD: gnf13.115.241, Chr. 
13, 64cM, P = 2.39×10-3. 
Note: It was not possible to estimate G×G×GNkx effects using logistic regression models as 
in the G×GNkx case because of convergence failures. These failures were caused by two-locus 
genotype groups with 0 heart defects, causing undefined values after logit transformation. 
 
Statistical Analyses 
GEMMA was run in Ubuntu 14.04. All other statistical analyses were performed in the R 
Statistical Computing environment (version 3.3.1). T-tests and Z-tests used a two-sided alternative 
hypothesis. We used the R package “ppcor”39 to calculate Kendall’s partial rank correlation40,41 (τ) 
with a two-sided alternative hypothesis. Partial correlations allowed us to calculate non-parametric 
correlation while controlling for the mouse population and the number of defect cases. ANOVA 











Figure 2.1  The severity and incidence of a heart defect are negatively correlated.  
A) In humans, mild defects are more common than severe ones. The median survival without 
surgical intervention defines the severity of a defect 2. The panels show representative heart defects 
from Nkx2-5+/- pups. Arrows point to a secundum ASD, membranous and muscular VSDs, and the 
common atrioventricular canal in an AVSD. B) As in humans, the incidences of heart defects in 
Nkx2-5+/- newborns are inversely related with their severity (Kendall’s partial rank correlation  = 
-0.845, P < 0.01). Double outlet right ventricle (DORV) was present in 18 and 3 Nkx2-5+/- hearts 







Figure 2.2  Breeding scheme for inbred strain intercrosses 
We produced F1 hybrids by crossing wild-type FVB/N (F) or A/J (A) females to Nkx2-5
+/- 
C57BL/6N (B) males. We phenotyped newborn Nkx2-5+/-  F2 pups from both A×B and F×B 
intercrosses and F10 and F14 pups from the F×B advanced intercross. The advanced intercross was 
produced by random mating of non-siblings and non-first cousins beginning in the F3 and F4 




Figure 2.3  The quantitative effect of G×GNkx interactions on risk correlates with the severity of a 
heart defect 
A) Genetic loci modify the risk of specific heart defects in Nkx2-5+/- mice from the F×B and A×B 
intercrosses. The number of affected Nkx2-5+/- newborns genotyped for each defect is indicated. 
Normal Nkx2-5+/- littermates were genotyped as controls (N = 330 A×B and 1024 F×B). 
Suggestive and genome-wide significance thresholds are indicated in blue and red. B) and C) 
G×GNkx effects on risk, quantified as the percent variance explained by the most significant SNP 





membranous (•) VSD loci are analyzed together because the two VSD types have similar severity. 






Figure 2.4  The correlation between defect severity and effect size is not attributable to trivial 
explanations 
Neither A), the number of significant and suggestive loci detected nor B), the phenotypic 







Figure 2.5  G×G×GNkx effects correlate with the severity of a heart defect 
Representative plots depict the observed and expected incidence of a defect at a two-locus 
genotype. The expected incidence is calculated under the null hypothesis of non-interacting loci. 
The difference between the observed and expected incidences is the G×G×GNkx effect at a 
genotype. Not all differences are significant. A), B) ASD and VSD loci mainly contribute to risk 






effects are small relative to the unweighted average of incidences (UWA, scale bars) across all 
nine genotypes. C), D) Epistatic interactions between AVSD loci exert large G×G×GNkx effects. 
Consider two examples (*). The syn-homozygous, two-locus genotypes (AA-AA and BB-BB) in 
the A×B intercross effectively suppress risk. In contrast, half of the AVSDs in the F×B intercross 
are associated with an anti-homozygous, Chr 5 BB-Chr 16 FF genotype. e, G×G×GNkx effect sizes 
correlate with defect severity (Kendall’s τ = 0.195, P = 0.0017). AVSD effects are larger than ASD 
and VSD (Mann-Whitney U test). Significant G×G×GNkx effects were divided by the UWA and 
shown as absolute values because the net deviation of observed and expected incidences is zero. 
The sign indicates whether a significant effect increases (+) or decreases (-) risk. The hatch marks 
indicate the mean. Effects are color-coded by their two-locus genotypes, as given in the Punnett 
square for syn- and anti-homozygous, double heterozygous, and mixed genotypes. Alleles: B, 





Figure 2.6  Every possible interaction between G×G×GNkx modifiers for each defect type 
The observed incidences at two-locus genotypes of ASD, membranous and muscular VSD, and 
AVSD are shown between every pair of suggestive or genome-wide significant modifier loci found 
in both crosses. In the two cases where there is only one suggestive locus, the locus is plotted 




















































Figure 2.7  Genetic compatibility between two loci involved in G×G×GNkx interactions lowers 
the risk of heart defects in Nkx2-5+/- mice 
A), Statistically significant syn-homozygous G×G×GNkx effects between two modifier loci are 
more likely to be protective than expected by chance or compared to anti-homozygous effects. 
Anti-homozygous effects are less likely to be protective than expected by chance. Double-
heterozygous and mixed genotype effects are equally likely to be protective or deleterious. The 






F) A significant G×G×GNkx effect at a syn-homozygous genotype that is protective (risk ) or at 
an anti-homozygous genotype that is deleterious (risk ) is associated with congruent effects at 






Table 2.1     Modifier loci by cross and defect type 
F×B, -log(p).  A×B, LOD. Bold, genome-wide significant. Non-bold, suggestive. *, estimated marker. The closest SNP is indicated. 
The locus interval is bounded by the 1 LOD or -log(p) drop from the peak SNP
Cross Defect Peak SNP Locus interval LOD or -log(p) Risk Allele Candidate genes 
A×B ASD rs6238909 chr1:125665904-182054904 2.88 B Csrp1, Lefty1, Lefty2, Pitx2, Vangl2 
A×B ASD rs31135898 chr3:52939690-158052844 3.22 A Bmpr1b, Notch2, Pifo, Pitx2 
A×B ASD rs13478067* chr4:124165816-154991070 2.69 A  
A×B Mbr.VSD rs3659784 chr2:31172022-152809607 3.42 A Actc1, Acvr1, Bbs5, Jag1, Lrp2, Mkks, Ttc21b, Zeb2 
A×B Mbr.VSD rs27610338 chr4:100332046-154991070 5.60 A Ptch2 
A×B Mbr.VSD rs13479701 chr8:14759093-62208384 3.81 A Hand2, Vegfc, 
A×B Mbr.VSD rs13482119 chr14:17628076-67124319 2.92 B Bmp4, Bmpr1a, Esco2, Gata4, Ift88, Myh6 
A×B Mbr.VSD rs30415214 chr19:23376527-53761523 3.55 B Acta2, Fgf8 
A×B Mus.VSD rs13479794 chr8:14759093-108947107 3.77 A Bbs2, Gdf1, Hand2, Nfatc3, Sall1, Vegfc 
A×B Mus.VSD rs13482037 chr13:96099181-118789220 5.87 B Fgf10, Isl1 
A×B AVSD rs13477291 chr3:75914491-136196844 4.98 A Notch2, Pifo, Pitx2 
A×B AVSD rs27610338* chr4:100332046-154991070 3.40 A Ptch2 
A×B AVSD rs13478337 chr5:35506765-129965381 4.08 B 
Cc2d2a, Evc, Evc2. Pkd2, Ptpn11, Med13l, Tbx3, 
Tbx5 
F×B ASD rs6304156 chr9:121915911-123153990 3.02 B  
F×B Mbr.VSD rs6292642  chr6:94055997-111299794 6.12 B Foxp1 
F×B Mbr.VSD rs3657963   chr8:15279371-17579118 4.98 F Csmd1 
F×B Mus.VSD rs6349084 chr6:85961013-104553235 3.13 B Prickle2 
F×B AVSD rs6255362  chr5:116106456-134045067 4.74 B Ptpn11, Med13l, Tbx3, Tbx5 
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High-resolution mapping of the maternal age-associated risk of 










Advanced maternal age is an underappreciated risk factor for congenital heart disease 
(CHD) in humans. Some may attribute this risk solely to the age-related decline in oocyte quality 
and an accumulation of genetic mutations. However, the risk remains even after excluding children 
with major syndromes or aneuploidy1.  
The laboratory of Patrick Jay was the first to demonstrate an analogous maternal age-
related CHD risk in mice. Using an Nkx2-5+/- mouse model of CHD, they demonstrated that each 
additional month of maternal age increased the offspring CHD risk by ~10% (Ref. 2). Copy 
number analysis in the mice excluded any meaningful effect of aneuploidy or large copy number 
variants. To determine if the maternal age risk is due to old eggs or physiological factors within 
old mothers, the ovaries of young mouse mothers were reciprocally exchanged for those of old 
mothers. The results conclusively showed that the elevated risk of CHD, specifically ventricular 
septal defects, in Nkx2-5+/- pups is due to physiological factors from the aging mother, not time-
dependent damage to the eggs3. Subsequent experiments showed that the age effect can be 
mitigated if the mother voluntarily exercises by running on a mouse wheel. The positive effect of 
aerobic exercise highlights the possibility that if the causal factors are identified, therapeutics, 
targeted at the mother, can mimic the effects of exercise and suppress age-associated CHD risk in 
humans.  
Following these profound discoveries, the next steps were not so clear because the maternal 
effect could be anything in the mother that changes with age. The most prudent approach is to use 
an unbiased method to identify the driving factor in the mother, rather than pursuing one of many 
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possible angles. Fortunately, there was one key observation that guided the path forward: the 
magnitude of the maternal age effect varies by the mother’s genetic background (Figure 3.1) This 
variation establishes that the age-related risk is a quantitative genetic trait that is amenable to 
genetic mapping. To associate our phenotype to specific genes, we need a genetic tool that enables 
sufficiently high mapping resolution; this tool is an advanced intercross line Darvasi and Soller4.  
 
High-resolution genetic mapping in an advanced intercross line 
The resolution of genetic mapping depends on the number of meiotic crossover events that 
have occurred since the original founder pair. It is the random shuffling of chromosome segments 
during meiosis that allows trait-associated genotypes to segregate with phenotypes5,6. 
Experimental backcrosses and F2 intercross analyses only have one generation of recombination 
events, thus the mapped loci have confidence intervals that typically comprise hundreds of 
candidate genes7. Contrarily, advanced intercross lines (AILs) boost the recombination frequency 
by randomly crossing F2 progeny for several generations, without mating individuals with common 
grandparents4. This process results in a panel of genetically unique mice. The mapping resolution 
increases linearly with additional intercross generations.  
Dr. James Cheverud has developed a 56th generation advanced intercross (F56) by 
intercrossing Large and Small (LG/J×SM/J) mouse strains. Many generations of meiotic 
recombination events have expanded the F56 genetic map 28-fold relative to an F2 population 
(Figure 3.2). Linkage mapping in the F56 population will yield loci spanning ~600kb, an interval 
that contains an average of three genes. Earlier generations of this LG/J×SM/J advanced intercross 
have been used successfully to map narrow genetic loci contributing to various complex traits 
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including obesity8, bone length9, metabolism10, anxiety7 and tissue regeneration11. Cheverud’s AIL 
was used to identify candidate genes (Aff3, Fam18a, Syn3 and Ank) for ectopic calcification12.  
Mapping the maternal age-associated risk of CHD in the F56 LG/J×SM/J dams presents an 





 Our team collected a total 17,568 mouse pups from 289 LG/J×SM/J dams 56th generation 
advanced intercross (LSAI) dams, 17,425 were available for analysis. The experimental cross was 
optimized to generate Nkx2-5+/-  pups, while allowing for homozygous genotypes at all potential 
modifier loci (Figure 3.3). We crossed LSAI sister pairs (littermates) to an Nkx2-5+/- F1 hybrid 
male that was either B6;LG or B6;SM. Using these males ensures the offspring population will 
express any recessive CHD risk modifiers. From the total pups collected, there were 8634 Nkx2-5 
mutants. A one sample z-test showed that the number of heterozygous pups did not differ from the 
expected 50% ratio (P = 0.234).  
 
Atrial septum and muscular septum defects reveal a large maternal age effect 
 CHD phenotyping began on a cohort of 7242 Nkx2-5+/- pups. First, I determined the 
incidence of the four most common heart defects: atrial septal (ASD), membranous ventricular 
septal (Mbr. VSD), muscular ventricular septal (Mus. VSD) and atrioventricular septal (AVSD) 
defects (Figure 3.4A). It was clear that ASDs are common and AVSDs are the least common, as 
we expected from previous experiments.  
To recapitulate the maternal age-dependent risk of CHD in humans, it is essential that CHD 
risk increases proportionally with maternal age. To determine whether the maternal age effect 
exists, we compared CHD incidence of mouse pups from young mothers (≤120 days old; N = 
1613) to pups from old mothers (≥250 days old; N = 3276) (Figure 3.4B). I found significant 
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maternal age effects for all defect types, but Mbr. VSD and AVSD maternal age effects were 
weaker. A logistic regression model further supports these observations (Figure 3.5).  
 
The maternal age effect on CHD risk varies significantly between mothers 
 Although there is a robust maternal age effect for ASD and Mus. VSD, the most important 
factor in mapping the maternal age effect is variation in the effect among LSAI mothers. To test if 
there is significant variation in the age effect, I used a logistic regression model (see Methods) to 
determine if the incidence of heart defects is dependent on an interaction between mothers and the 
maternal age. A significant interaction term provides evidence for mappable variation in the 
maternal age effect. The logistic regression model showed significant interactions between mother 
and maternal age for all defects (Table 3.1). 
 Using a similar model as before, I estimated the change in the age effect for each mother 
individually. The resulting odds ratios (ORs) are point estimates describing the CHD risk per 
month of maternal age. These ORs can reach as high as 3 (Figure 3.6). However, it important to 
note that many of the point estimates have large standard errors because of the relatively small 
number of offspring available per mother. This explains the lack of error bars in Figure 3.6. There 
is likely a substantial amount of noise in these point estimates. However, this should not matter 
for two reasons: 1) The point estimates provide a reference for the magnitude and range of the age 
effects, 2) these results confirm the logistic regression model demonstrating that there is significant 
variation in the maternal age effect. The agreement between the two models suggests that genetic 




Genotyping by sequencing identifies over 30,000 high quality SNPs 
 Single nucleotide polymorphism (SNP) genotyping was performed through two methods:  
1) Genotyping by sequencing method (GBS)13,14 and 2) Illumina GeneSeek Genomic Profiler 
GigaMUGA15. Over 90% of LSAI mothers were genotyped with GBS, the remaining that were 
genotyped with the Illumina array were to circumvent poor DNA quality.  
GBS uses restriction enzymes to systematically reduce the size of the genome, so that the 
same DNA regions are sequenced in all samples. This allows high sequencing depth, which is 
essential for SNP variant calling. As a visual assessment of the sequencing and variant calling 
quality, I plotted the distribution of variants called by GBS in comparison to the regions known to 
be polymorphic between LG/J and SM/J (Figure 3.7). The 36,220 SNPs we detected closely fit the 
distribution of expected SNPs. Our SNPs achieve roughly 90% genome coverage. 
The Illumina GigaMUGA array contains 143,000 SNPs that captures polymorphisms from 
over 150 different mouse strains. After quality control with the same thresholds as used for the 
GBS samples and removing duplicate or invalid SNPs, there were 24,683 SNPs remaining for 20 
samples (Table 3.2). I tested the concordance between GBS and GigaMUGA for two samples that 
were genotyped on both platforms (LSAI 101058 and 101080). I found that only 243 SNPs were 
genotyped on both platforms. After removing rows with missing data, I found that 94% and 82% 
of SNP calls overlapped between the two replicates, respectively. It appeared that the 
disagreements were almost entirely due to the GBS method missing a heterozygous call, only 
detecting one allele. 
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 Because most samples were genotyped using the GBS platform, I imputed the SNPs called 
by GBS in the samples genotype with the GigaMUGA platform. Imputation was performed using 
the R package, QTLRel, to calculate genotype probabilities, and then the probabilities were 
converted to an allele dosage/mean genotype, which incorporates the level of certainty in the 
genotype value. After all the QC and processing steps, there were 36,220 SNPs available for 262 
total LSAI mothers with 7242 pups. 
 
Mapping the maternal age-associated risk of CHD 
 Using a linear mixed model (see Methods), I modeled the phenotype for each pup in a 
case–control or binary format. I classified controls as pups that lacked any sort of heart defect, and 
cases were the pups that have the specific defect under analysis. This means that the pups with 
other heart defects were excluded from that specific analysis. I found that this was necessary 
because including pups with other defects as controls, was reducing power by confounding the 
control cohort. 
The independent variables are a combination of fixed and random effects. I estimated the 
fixed effects of maternal age, the mothers’ genetic effects (additive and dominant) at each locus, 
and pairwise interactions between maternal age and genetic effects on each pup’s risk of 
developing a specific heart defect. The interactions between maternal age and the genetic effects 
(Maternal Age × Additive effect; Maternal Age × Dominance effect) are the most important terms 
in the analysis because it will pinpoint the loci that drive the maternal age effect. Our model also 
controlled for the paternal type as a binary covariate. 
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In early iterations of this analysis, I noticed that several LSAI mothers had offspring with 
defect incidences much lower than the population average, which greatly reduces the likelihood of 
detecting a maternal age effect when the offspring have effectively no risk of developing a specific 
defect (Table 3.3). To control for this scenario, I included the defect incidence from all offspring 
per mother as a covariate to control for the variation in the maternal age effect estimates that could 
be due to low CHD risk. I also controlled for unequal relationships between mothers by including 
a random effect of relatedness. This model was fit with custom scripts for the lmekin16 R function, 
which is a specialized wrapper for the coxme package that adds the capacity to model random 
effects with a genetic relatedness matrix (GRM) or a covariance matrix. I calculated covariance 
matrices using the functions in GEMMA. Genome-wide significance was set by Bonferroni 
correction based on the number of independent SNP markers17, 10,764 effective markers. Thus, 
genome-wide significance was set at p < 4.6×10-6 (0.05/10764) and the suggestive threshold was 
p < 9.30×10-5 (1/10764). 
 The maternal age effect greatly amplified ASD and Mus. VSD risk. One parsimonious 
hypothesis would suggest that the same maternal age effect loci will appear in both ASD and Mus. 
VSD cohorts. Thus, I conducted separate analyses for each defect to identify genetic modifiers of 
the maternal age effect (Figure 3.8A, B).  Upon inspecting the results, two things became clear: 1) 
there are several significant loci, particularly those for the ASD maternal age effect, and 2) there 
is no clear overlap between the loci from the ASD and Mus. VSD analyses. To remedy the latter 
observation, I combined the ASD and Mus. VSD cases into one analysis to ensure that the maternal 
age effect loci that I detect will affect both ASD and Mus. VSD. This analysis identified a 
significant locus on Chromosome 3, centered at 72,433,899 bp (Figure 3.9, Table 3.7). The some 
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of the nearest genes to this marker are Rapgef2, Fnip2, Ppid and Etfdh. These loci will be the target 
of future investigation, particularly those on chromosomes 3 and 8 because they are supported 
most strongly by the data.  
Other important data is summarized in Figures 3.10 – 3.12 and Tables 3.5 – 3.8. These data 
include manhattan plots for other maternal age defect analyses, effect plots, loci intervals and 







 Congenital heart disease is a very complex biological phenomenon. Aside from the effects 
of mutations and genetic modifiers within an individual, there are external factors that can also 
have a large impact on CHD risk. Environment is frequently used as a catch-all term to include all 
heritability that is not explained by an individual’s genes. Although this simplifying assumption is 
useful at times, it does not allow a full investigation of the genetic architecture of complex traits.  
In our work here, we go against the grain and explore the role of maternal effects in CHD. 
Maternal effects are instances where a phenotype in the mother alters a phenotype in the offspring, 
independently of the genes she transmits to the offspring. There are many examples of maternal 
effects throughout nature. For instance, seasonal changes in temperature and light cycle determine 
whether an aphid mother will produce parthenogenetic or sexual offspring, and maternal sensitivity 
to these environmental changes varies within populations18. In mouse embryos, Tgf-β1 null 
mutations are lethal only when the mother is also Tgf-β1 null. Maternal expression of Tgf-β1 during 
gestation is sufficient to rescue normal development. Perhaps the most well-known maternal effect 
in humans is the “thrifty phenotype”, also known as the Barker hypothesis19. Barker noticed that 
adults that were in utero during the Irish potato famine suffer a substantially elevated risk for 
metabolic syndrome. He hypothesized that maternal malnutrition during that period caused lasting 
changes to the embryonic metabolism as an adaptation to scavenge as many nutrients as possible 
to maintain development. In adults, this can lead to an overly anabolic metabolism, which increases 
the risk for several cardiometabolic diseases. 
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 The maternal age-associated risk of CHD was first observed in humans and recapitulated 
in our mouse model of CHD. The mice showed that the maternal age effect is ameliorable with 
voluntary exercise. This gives us hope that it will be possible to create therapeutics that target this 
age effect and potentially other risk factors for CHD. Although our work is still in progress, I have 
identified loci that potentially contain genetic modifiers of the maternal age effect. I hypothesize 
that the loci we may identify will contain genes that are components of classical aging pathways 
such as Mtor, FoxO3a, Sirt1 or Igf1. Because exercise mitigates the age effect, I may identify 
exercise responsive myokines20, or energy homeostasis genes such as Leptin. I may also find 
unexpected genes to be associated with the maternal age effect. These genes may not be recognized 
for roles in offspring development possibly because of antagonistic pleiotropy. Antagonistic 
pleiotropy occurs when gene effects that enhance fitness early in life, also have pernicious effects 
later in life21. For instance, a gene variant that affects reproductive hormone homeostasis to allow 
earlier reproduction, may negatively affect the female body at advanced age, thus enhancing the 
maternal age effect on CHD.  
 
Current state and future directions for genotyping 
At our current stage of progress in this project, we are in the process of genotyping all the 
remaining LSAI mother. This includes 61 LSAI mother samples that had missing or poor-quality 
spleen DNA, whose livers were used for GBS. There were also 25 LSAI mothers whose carcasses 
were lost in the Chicago shuffle; we are using GBS for ~10 pups from each missing mother to 
infer her genotypes. Once these genotypes are available we can start to finalize our observations 




Current state and future directions for statistical modeling (technical details) 
As important as the genotyping effort, is the work on the statistical model used to map the 
maternal age effect. Early in the analysis, I noticed that the model may have some issues with 
pseudoreplication because the response variable in my model are individual pups that are treated 
as independent samples, when truly the pups from the same mother are correlated. 
Pseudoreplication is the statistical phenomenon where the samples from which observation are 
collected are assumed to be independent, when in reality the samples show some sort of 
correlation. A simple example of pseudoreplication gives the rationale for the paired T-test22: when 
taking repeated measures from the same sample of individuals, the subsequent measurements are 
going to be correlated within an individual. Many researchers, including myself, assumed that the 
using a linear mixed model with a random intercept would fully account for the non-independence 
of individuals. Failure to account for the correlation between the rates of change in non-
independent samples can inflate the Type 1 error rate because the standard errors are 
underestimated23. 
Dr. Cheverud also noticed that there is an issue with pseudoreplication and suggested two 
remedies: 1) use the difference in the early and late incidence of CHD per LSAI mother as the 
response variable or 2) adjust the degrees of freedom for the model to match the number of mothers 
in the study, not the number of pups. These are great options that would alleviate the issue of 
pseudoreplication, however, they introduce other challenges. Option 1 becomes difficult for 
mothers with fewer pups because the estimates of their age effect will be poor because they have 
few samples, but their age effect (the difference) is weighted equally with other mothers more pups 
82 
 
and more confident estimates. Option 2 becomes difficult because the lmekin R function does not 
permit manually dictating the degrees of freedom. It would require using SAS PROC GLIMMIX, 
which I do not have available. If this software becomes available this may become a good option. 
A well-referenced24 study by Schielzeth and Forstmeier23 found that including a random 
slope term, along with the random intercept term in the linear mixed model, will account for issues 
with pseudoreplication. This is supported by the fact that the random slope accounts for the non-
randomness in the rates of change that are inherent in groups of correlated samples. Pursuant to 
this information, I did a small test to compare the performance of the linear mixed model with 
random intercept only to a model that added a random slope of maternal age. I used one SNP and 
the same overall model used for mapping and compared the p-values and standard errors. I found 
that the results differed negligibly, as in SE and beta differences of 1 millionth or less. Although 
this is a very crude approximation for the genome-wide set of SNPs, it suggests that 









Mouse strains and crosses 
The Cheverud laboratory produced and housed 292 LG/J×SM/J F56 advanced intercross 
female mice (LSAI mothers). The LSAI mothers were generated as sister pairs to be crossed to a 
Nkx2-5+/- hybrid male of either C57BL6/J;LG/J or C57BL6/J;SM/J, see Figure 3.3 for the cross 
schematic. Three mothers either died prematurely or failed to produce offspring, bringing the final 
number of LSAI mothers to 289. We bred LSAI mothers with the hybrid males for the duration of 
her reproductive lifespan, expecting an average 10 litters with roughly 8 pups per litter, a total 
23,120 pups.  
 
Collection and phenotyping of hearts 
We collected 17,568 total offspring from the LSAI mothers, with maternal age at birth 
ranging from 55 – 429 days. We collected the pups at P0 to avoid the loss of those with severe 
heart defects. After excluding pups with low DNA concertation or missing samples, there were 
17,425 pups remaining. We expect that 50% (8,712) of the pups will carry the Nkx2-5 mutation; 
we recovered 8,634 mutants (49.54%), which was not significantly different from the expectation 
(one-sample z-test, P = 0.23). 
We fixed the thoraces of all Nkx2-5 mutants in 10% neutral formalin. Hearts were 
completely sectioned in the frontal plane at 6 µm thickness. Every section was collected, stained 
with hematoxylin and eosin, and evaluated by two highly trained individuals. All defects were 
diagnosed by the morphology of the atrial and ventricular septae, semilunar and atrioventricular 
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valves, chambers and the anatomic relationships between them. Secundum ASDs were 
distinguished from a patent foramen ovale based on the size of the latter in wild-type hearts. ASDs 
were counted in these analyses if they reached an internal Jay lab sizing threshold of 5 (50% of the 
length of the atrial septum).  
 
Detecting variation in the maternal age effect using a generalized linear model 
To test for variation in maternal age effects between mothers, I used the following 
generalized linear model: 
𝑪𝑯𝑫 = 𝑷𝑻 + 𝑴𝑰 + 𝑴𝑨 + (𝑴𝑰 ∗ 𝑴𝑨) 
where CHD is a binary case-control indicator that denotes the presence of a specific defect or the 
a completely normal heart, PT accounts for the effects of B6×LG versus B6×SM F1 hybrid father, 
MI is the maternal identity, MA is the effect of the mother’s age, and MA*MI is the interaction of 
maternal age and maternal identity. The interaction term is critical because it represents the 
variation in individual maternal age effects for mapping. I tested the significance of each term with 
an analysis of deviance using a likelihood ratio test. 
 
Single nucleotide polymorphism genotyping 
Genomic DNA was isolated by phenol-chloroform extraction and dissolved in 1.2mL of 
0.5x TE buffer. SNP genotyping was performed with two methods 1) genotyping by sequencing 
(GBS) and 2) Illumina GGP GigaMUGA array. 
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GBS services were performed by Beijing Genomics Institute (BGI) in Shenzhen, China. 
We prepared the DNA samples by diluting them to ~ 300ng/μL with 0.25x TE and depositing 
them in 96-well plates, along with 3 samples with known genotypes. We used an Nkx2-5+/- 
C57BL6/J male, and pure LG/J and SM/J samples. After quality control steps at BGI, the DNA 
was digested with ApeKI restriction enzyme, size filtered for ~200 – 300bp fragments, and 
paired-end sequencing was performed on the Illumina HiSeq 4000. 
SNP-calling on the Illumina GGP GigaMUGA array was performed by Neogen 
Corporation in Lincoln, NE. DNA samples were prepared the same way as for GBS. However, we 
included two LSAI mother samples (101058 and 101080) that had been genotyped with GBS as a 
technical replicate and to serve as a comparison between the two methods. The GigaMUGA arrays 
were analyzed on Illumina Goldengate platform and yields 143,000 SNPs. 
 
Bioinformatics processing and analyses 
Sequence data from GBS was provided on 500GB hard drives. The paired FASTQ files 
provided are already demultiplexed and adapter trimmed. The read counts from the samples ranged 
from 1.5 – 5 million reads. Using BWA MEM (version 0.7.5a-r405) on Linux Ubuntu (version 
14.04 LTS), I aligned the files to the GRCm38 mouse reference (called 
“Mus_musculus.GRCm38.dna_sm.chromosome.1.fa”). Note: the file is named chromosome 1, 
which is a naming error on the Ensembl FTP site because this file contains the entire genome. The 
SAM files were converted to BAM files and were indexed. The BAM files were fed into a 
customized version of the Fast-GBS25 analytical pipeline run on the Washington University CHPC 
High Performance Computing Cluster, which runs Linux of unknown version. Fast-GBS 
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incorporates the program Platypus for variant calling. Fast-GBS produces a VCF file that I 
converted into a text file for downstream processing in R. I used custom scripts in R to clean and 
parse the GBS data for mapping. 
I identified nearly 400,000 polymorphic nucleotides. After filtering for known LG/J vs. 
SM/J polymorphisms26, minor allele frequency (MAF) > 0.20, < 20% missing per SNP and Hardy-
Weinberg equilibrium there were 36,220 SNPs remaining for 188 LSAI samples. On average, there 
is one SNP per ~100 kbp. Such a high SNP density allows very high-resolution mapping, despite 
only ~5000 SNPs being needed to map in this F56 population. 
We received the GigaMUGA data via a download link containing text and Excel files. The 
file containing the raw data is called “Washington_Universit_Akhirome_MURGIGV01_ 
20180426_FinalReport.txt”. The R package argyle27 was specially designed to perform QC steps 
on data from the Illumina GGP series of mouse genotyping arrays. The data showed an average 
90% call rate across all samples. I extracted the SNP data from the QC software for use in mapping 
analyses. 
 
Imputing SNP data and merging datasets 
 Because >90% of LSAI mothers were genotyped with GBS and only 243 SNPs 
overlapped with GigaMUGA, I imputed the GBS SNP positions in the 20 GigaMUGA mice to 
merge the two datasets. Using QTLRel (version 0.2-15), I calculated the genotype probabilities of 
the missing SNPs and converted them to BIMBAM format, which uses the mean genotypes or 
allelic dosage values. BIMBAM format accounts for the uncertainty in imputed genotype values 
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by allowing any range of numbers between 0 and 2 (numerical coding for the 3 genotypes). After 
combining the data with the GBS samples, there were 262 total mothers with SNP data available 
for analysis.  
 
Genetic association analyses 
To map the maternal age effect, we conduct genetic association tests in R, using a custom 
parallelized version of the lmekin16 function in R (version 3.3.1). I tested associations between 
SNPs in the mother and her maternal age effect using a linear mixed model:  
𝑪𝑯𝑫 = 𝑷𝑻 + 𝑨 + 𝑫 + 𝑴𝑨 + 𝑰𝒏𝒄 +  (𝑨 ∗ 𝑴𝑨) + (𝑫 ∗ 𝑴𝑨) + 𝑲 + 𝒆 
where CHD is a binary indicator (0,1) for the absence or presence of a heart defect in an 
offspring, A (D) is the additive (dominance) effect of the genotypes at the maternal locus, K is the 
random effect of kinship between mothers, Inc is the incidence covariate that accounts for each 
mother’s intrinsic CHD susceptibility that is transmitted to the offspring, and e is the error vector. 
(A × MA) and (D × MA) are the interactions of maternal genotype and maternal age. These 
interaction terms are critical because they pinpoint the genetic regions that alter how much the 
maternal age effect alters CHD risk.  
 
Statistical analyses 
 All statistical analyses and functions not otherwise specified were performed in the R 









Figure 3.1  Genetic variation in the maternal age effect indicates it is a quantitative trait 
Female mice with different genetic backgrounds have varying levels of a maternal age effect on 
VSD risk, suggesting that the differences are genetically determined. 





Figure 3.2  Breeding scheme for the F56 LG/J×SM/J advanced intercross line  
The LSAI advanced intercross began with an SM/J male and LG/J female28. 






Figure 3.3  Experimental cross diagram for the F56 mapping population 






Figure 3.4  ASD and VSD risk is subject to strong maternal age effects 
A) We have phenotyped 7242 pups (84% of the total). These pups carry the most leverage in our 
analyses because they are at the extremes of maternal age;  B) the pups shown in the Young mom 
(<120 days) and Old mom (>250 days) groups comprise all pups that fit that category. ***** 









Figure 3.5  The effect of maternal age on each defect varies broadly 
The odds ratios were estimated using the following generalized linear model: 
Defect ~ Father + Maternal Age, where Defect is the binary indicator for the presence of the 
specific defect vs. all other pups (irrespective of defect status), Father is a covariate for the hybrid 





Figure 3.6  Estimates of the maternal age effect, per mother 
Defects with larger maternal age effects, ASD and Mus. VSD, also had significantly more 
between- mother variation. A color gradient was added to emphasize that there are data points 




Figure 3.7 Distribution of Chromosome 18 GBS SNPs compared to the Reference 
The red bars show the SNP counts from GBS per 2 Megabases compared to the reference SNP 
density distribution, which is based on whole genome sequence of both LG/J and SM/J26. One 
representative chromosome is shown here for the sake of legibility. 
 
  




Figure 3.8  Manhattan plots of the maternal age effect on ASD and Mus. VSD show many loci, 






A) There is 1 locus that surpassed the genome-wide significance (red line) and 11 others that only 
exceed the suggestive threshold (blue line) for the ASD maternal age effect. B) Mus. VSD has no 




Figure 3.9  Combining the ASD and Mus. VSD analysis reveals common maternal age loci 








Figure 3.10  Manhattan plots of the maternal age effect on Mbr. VSD and AVSD show only 1 
suggestive locus 






Figure 3.11  Analyzing the maternal age effect for all defects combined reveals the best 
consensus candidate loci 
Although only one significant locus was detected, this is on Chr. 3 72Mb, which overlaps with loci 







Figure 3.12  Effect plots illustrating the maternal age effect for the most significant loci 
Young and Old Mom are as previously described. OR (Odds Ratio) is from a logistic regression 










Table 3.1  P-values from the GLM for between-mother variation in the age effect 




ASD 0.011 0.42 2.2E-16 9.9E-14 
Mus. VSD 9.2E-7 0.465 2.2E-16 2.2E-16 
ASD + Mus. VSD 9.7E-13 0.86 2.2E-16 2.2E-16 
Mbr. VSD 1.6E-4 0.49 5.5E-15 1.8E-6 
AVSD 0.0086 0.58 0.0087 8.122E-16 
All Defects 2.2E-16 0.91 2E-16 3.9E-8 
 
Variation in the maternal age effect for each heart defect was performed using a GLM with the 
same terms as given in the table (see Methods). Maternal age explained a significant amount of 
the offspring’s risk for all defect types, but not paternal type. All defects had significant variation 
in the age effect based on maternal identity (Mother × Maternal Age interaction term). Insignificant 




































# Mothers w/o 
defect 
# Mothers w/o defect 
(≥ 15 total pups) 
ASD 42 18 
Mus. VSD 39 20 
Mbr. VSD 51 27 
AVSD 79 27 
Total 206 157 
 
Table 3.3  Number of LSAI mothers that did not produce a pup with a given heart defect 
For the LSAI mothers with no pups that have a specific defect make it impossible to estimate the 
maternal age effect. This data suggests that mapping power could be improved by excluding 
females that lack sufficient offspring with a given defect.  
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Instead of directly genotyping these females, we will sequence their offspring and use their 
genotypes to infer the maternal genotypes.  
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Table 3.5  Counts of LSAI mothers and pups used in the various mapping analyses 
Defect # LSAI Mothers  # Pups 
All Data 262 7242 
All Defects 252 7171 
ASD 193 4047 
Mus. VSD 214 4816 
ASD + Mus. VSD 235 5506 
Mbr. VSD 201 4356 
AVSD 161 3369 
 
These data started with the All Data, which includes mothers with <10 pups. After removing those 
mothers, All Defects were those mothers and pups used in the All Defects mapping analysis. All 





Table 3.6  All suggestive and significant loci from all mapping analyses of the maternal age 
effect on CHD risk 




Mus. VSD 2 27059965 27058824 27062432 4.252 S Suggest 
ASD+MUS 3 72433899 70232592 76330685 5.432 S Signif 
All Defects 3 72433899 71312230 72564314 5.000 S Suggest 
ASD+MUS 3 78160123 77705412 78341524 5.149 S Suggest 
Mus. VSD 3 78160123 77705412 78341524 4.796 S Suggest 
ASD 4 10412170 9985083 10534025 4.149 S Suggest 
ASD+MUS 5 10187223 10186856 10200719 4.699 S Suggest 
Mus. VSD 5 10338120 10204461 10370589 4.721 S Suggest 
AVSD 5 122679822 122628998 122707862 4.456 S Suggest 
Mus. VSD 5 148575239 148493190 148591437 4.854 L Suggest 
ASD+MUS 5 151301096 151074156 151642464 4.638 L Suggest 
Mus. VSD 5 151301096 151074156 151642464 4.444 L Suggest 
ASD 6 93617919 93553398 93641297 4.076 S Suggest 
ASD 6 136331809 136292833 136347816 4.409 L Suggest 
ASD 7 70787371 70625510 71400860 5.000 S Suggest 
ASD+MUS 8 95062332 95056619 95082495 5.000 L Suggest 
ASD 8 95107702 95056619 95121718 4.745 L Suggest 
ASD 10 27826308 27387809 27844166 4.523 S Suggest 
ASD 10 57815137 57755032 57848120 4.523 L Suggest 
ASD 10 89558992 89111526 89616052 5.357 L Signif 
ASD 11 33993249 33767594 34385148 4.770 S Suggest 
ASD 13 38200712 38074675 38580221 4.886 S Suggest 
Mus. VSD 14 87458271 87423575 87467896 4.066 L Suggest 
All Defects 17 27045339 27038183 27057323 4.161 S Suggest 
ASD+MUS 17 27319123 27249150 27335308 4.071 S Suggest 
ASD+MUS 17 27514130 27511552 27519073 4.260 S Suggest 
ASD+MUS 17 27804653 27796945 27811334 4.638 S Suggest 
ASD 17 49245677 49074142 65778923 4.432 S Suggest 
ASD+MUS 18 52816516 52617697 52838921 4.174 L Suggest 
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ASD 18 52826440 52485633 53103241 4.347 L Suggest 
Mus. VSD 18 78669929 76871126 78779875 4.328 L Suggest 
All Defects X 168241499 161397927 168700752 4.538 S Suggest 
 
This table is organized by chromosome and locus to emphasize overlapping loci from different 
analyses. The significant loci are highlighted in red. The lower and upper bounds were 
determined by a flanking drop of 1 “log10(p) unit” from the peak SNP. In the Risk Allele 





Table 3.7  All protein-coding genes from the Chr. 3 loci 
Chr. 3   70 – 77 MB 
Peak: 72433899 LOD 5.4318 | Risk allele: S  
Gene Chr Start End 
Otol1 3 70007613 70028708 
Sis 3 72888557 72967863 
Slitrk3 3 73047265 73057803 
Bche 3 73635808 73708415 
Zbbx 3 75037907 75165034 
Serpini2 3 75242370 75270078 
Wdr49 3 75274988 75482156 
Pdcd10 3 75516490 75556856 
Serpini1 3 75557547 75643495 
Gm29133 3 75748197 75787653 
Golim4 3 75875084 75956949 






Table 3.8  All protein-coding genes from the ASD Chr. 10 locus 
Chr. 10   89 – 90 MB 
Peak: 89558992 LOD 5.3565 | Risk allele: L 
Gene Chr Start End 
Ano4 10 88948994 89344762 
Gas2l3 10 89408823 89443967 
Nr1h4 10 89454234 89533585 
Slc17a8 10 89574020 89621253 
Scyl2 10 89638721 89686285 
Actr6 10 89711971 89732295 
Uhrf1bp1l 10 89744991 89819871 
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Synthesis and implications for CHD research 
 The inheritance and manifestation of congenital heart disease is a remarkably complex 
biological process. My research shows that complex genetic interactions within a predisposed 
individual can dictate whether the disease appears or not. I also show the profound impact that the 
developmental milieu can have on the risk of certain heart defects. However, the question remains 
as to how our findings will drive the future of CHD research. 
 My work on epistasis in CHD shows that the outcome of a de novo mutation is highly 
dependent on the combination of other inherited polymorphisms across the genome. This is the 
oligogenic model for CHD. Unfortunately, the methodology used in many large-scale sequencing 
studies automatically ignores the role of potentially deleterious variants transmitted from 
unaffected parents. This simplifying assumption is useful for reducing the complexity of large 
whole genome datasets, but it fails to represent the full genetic architecture of CHD. My results 
suggest that if we identify well-annotated networks of genes that physically interact during cardiac 
development (a feat in and of itself), when a de novo mutation is identified, we can query the list 
of gene interactions to look for inherited variants in those genes. 
One study recently applied a similar method to study genes with potential physical 
interactions in a CHD cohort1. on combined WES and array-CGH data in a study of trios with 
atrioventricular septal defects. The authors used a novel rare-disease inheritance model to detect 
de novo mutations as well as inherited compound heterozygous and rare homozygous gene variants 
across the genome. This model also assessed the burden of potentially deleterious variation in 
genes that had likely physical interactions. They found that their model was able to identify CHD-
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associated variants in 23% of trios with sporadic CHD. Interestingly, many of the trios had multiple 
predicted-deleterious variants in genes that have not been previously tied to CHD. Additionally, 
this study only considered inherited variants that potentially functioned by recessive disease 
mechanisms. This is likely because it is difficult to work with the large number of rare 
heterozygous variants that are inherited from the parents. 
Most cases of CHD are not caused by a single genetic event. Using my work as a proof of 
concept, studies of human CHD must change the assumptions away from a monogenic model to 
an oligogenic model. This assertion is supported by the fact that evolution favors robust or resilient 
genetic networks. If it only takes one mutation to derail cardiac development in all cases, the 
incidence of CHD would be much higher. My work shows that the combinations of genetic variants 
within a genetic interaction network can substantially influence whether a heart defect appears in 
susceptible individuals. This is even more true for severe heart defects, for which risk is more 
dependent on other interacting polymorphisms than for mild defects. 
Interestingly, I observed that AVSDs are rare in Nkx2-5+/- mice and in humans, suggesting 
that atrioventricular septum development is quite robust to genetic insults. I also found that the 
maternal age effect did not affect the risk of AVSD. This suggests that the atrioventricular 
compartment is robust to both genetic and environmental insults. This is logical because selection 
can exert heavier pressure on traits with higher fitness costs. These assertions are partially 
supported by the observation made by Brodwall et al. 2017 (Ref. 2), showing that the risk of severe 
CHD is 7 times higher when an older sibling has a severe heart defect compared to when the sibling 
has a normal heart. Contrarily, the risk is only 2.3 times higher than normal when the older sibling 
has a mild defect. Once one family member manifests a severe CHD, it indicates that there has 
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been a breakdown in the resilience mechanisms. Since there are likely many broken safeguards, it 
is likely that the siblings are each inheriting many risk factors from their parents, thus enhancing 
the recurrence risks in the family. Therefore, I hypothesize that severe CHD risk has a significantly 
higher heritability from inherited rather than de novo variants. Future work in partitioning these 
contributions will be necessary to validate this idea. 
 Because the effects of evolution are pervasive throughout biology3, it is likely that 
robustness influences all diseases with variable expressivity and penetrance. It has been suggested 
that robustness is a ubiquitous biological phenomenon4,5, therefore it is not surprising that 
evolution has shaped the architecture of biological networks to prevent the most severe 
phenotypes. Our finding that coadapted gene variants in mice can suppress CHD risk shows that 
it is the specific interacting variants that determine the level of robustness. Harmonious allele 
combinations generate favorable epistatic effects that can suppress the effects of deleterious 
mutations. If we identify modifiable factors that influence this risk suppression, then we would 
finally have an intervention to prevent CHD. Similarly, our work on the maternal age effect seeks 
to identify the physiological mechanisms through which aerobic exercise suppresses the maternal 
age effect. It is possible that these mechanisms could include robustness to stressors associated 
with aging. 
 In conclusion, my work on CHD explored the intrinsic and extrinsic factors that influence 
CHD risk. While there is much left to be done, progress is imminent. As the costs of sequencing 
and analytical assays decrease, it will become possible to do the large-scale tests in human 
populations. Results from these studies will eventually lead to interventions that will better treat 
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SNP ID Chr. 
F2 cM, Cox 
sex-avg. 
 SNP ID Chr. 
F2 cM, Cox 
sex-avg. 
rs13475818 1 16.4470 
 
rs30458137 9 32.7528 
rs3163007 1 32.3070 
 
rs33720457 9 40.8760 
rs13475934 1 39.5110 
 
rs3710939 9 57.9830 
rs3684360 1 54.7000 
 
rs13480488 10 3.0060 
rs3701630 1 69.1070 
 
rs13459187 10 5.1430 
rs6238909 1 84.9310 
 
rs29329268 10 5.8055 
rs13476354 2 10.3282 
 
rs13480521 10 7.8605 
rs13459062 2 21.8060 
 
rs13459119 10 9.7540 
rs3659784 2 62.0980 
 
rs29325765 10 47.0500 
rs27349879 2 75.4070 
 
rs13480773 10 62.2764 
rs3659658 2 89.4670 
 
rs26864121 11 13.3116 
rs3676540 3 6.8289 
 
rs13480991 11 25.4920 
rs29807239 3 14.2680 
 
rs13481091 11 43.7211 
rs3716258 3 24.0970 
 
rs27059631 11 58.9000 
rs3706378 3 33.7550 
 
rs3706128 11 70.2894 
rs13477291 3 43.5124 
 
rs13481256 11 82.9570 
rs31135898 3 53.0931 
 
rs3678500 12 9.9405 
rs30509660 3 63.0360 
 




rs3685116 3 72.3035 
 
rs13481459 12 22.8396 
rs13477517 3 81.6622 
 
rs6333493 12 28.7260 
rs27682879 4 7.5557 
 
rs13481595 12 45.4220 
rs27807782 4 14.0000 
 
rs3705279 13 7.2572 
rs3719378 4 45.7060 
 
rs13459140 13 17.8688 
rs6195490 4 57.6654 
 
rs13481783 13 21.2100 
rs27610338 4 69.0510 
 
rs29237897 13 35.7893 
rs13478067 4 86.1670 
 
rs29229165 13 50.4979 
rs13478133 5 9.9680 
 
rs13482037 13 67.2100 
rs13478182 5 18.1590 
 
rs30637674 14 7.0800 
rs13478245 5 26.8220 
 
rs13482119 14 18.6570 
rs3684754 5 36.0449 
 
rs3715961 14 23.9629 
rs13478337 5 41.8192 
 
rs3653455 14 34.6140 
rs3655541 5 51.4340 
 
rs6306220 14 44.0387 
rs3715788 5 60.5724 
 
rs13482356 14 56.1650 
rs6237258 5 68.2580 
 
rs32275246 15 8.5380 
rs13478585 5 85.2381 
 
rs13482486 15 9.4930 
rs6172481 6 1.8060 
 
rs13482587 15 21.1460 
rs6271324 6 15.4780 
 
rs32164372 15 38.0150 
rs13478830 6 32.5560 
 
rs3695692 15 48.0369 
rs6292642 6 48.9280 
 




rs6361894 6 63.4350 
 
rs4169065 16 21.7827 
rs13479152 7 12.4855 
 
rs4189683 16 34.3570 
rs32082888 7 25.4805 
 
rs4210345 16 45.7803 
rs3675728 7 39.8674 
 
rs13459152 17 22.5930 
rs4137968 7 54.4590 
 
rs13483049 17 29.7243 
rs13479530 7 73.1870 
 
rs33633158 17 45.4911 
rs3023176 8 7.5870 
 
rs6358426 18 10.1000 
rs13479701 8 22.3824 
 
rs29976462 18 23.8762 
rs13479794 8 31.5500 
 
rs3656892 18 42.5727 
rs13479955 8 50.0740 
 
rs30997811 19 18.3527 
rs13479979 8 56.1970 
 
rs30415214 19 35.9722 
rs13480121 9 16.3358 
 
















rs6269442 rs6269442 1 1.614  rs3667475 rs3667475 8 34.488 
rs13475701 rs13475701 1 1.744  rs13479830 rs13479830 8 35.127 
rs13475706 rs13475706 1 1.889  
CZECH-
8_78291790 rs36926924 8 37.450 
rs3684358 rs3684358 1 2.060  rs13479871 rs13479871 8 41.475 
rs13475729 rs13475729 1 3.749  rs6257357 rs6257357 8 41.611 
rs3671256 rs3671256 1 5.009  rs13479882 rs13479882 8 42.129 
rs13475750 rs13475750 1 6.153  rs13479884 rs13479884 8 42.330 
rs6404446 rs6404446 1 6.442  rs6391152 rs6391152 8 43.853 
mCV23695025 rs31949292 1 8.486  rs13479922 rs13479922 8 44.877 
rs6173215 rs6173215 1 8.692  rs4137596 rs4137596 8 46.663 
mCV24784983 rs31917015 1 10.425  rs6285803 rs6285803 8 48.120 
rs6166266 rs6166266 1 10.731  rs6287320 rs6287320 8 48.493 
rs3677683 rs3677683 1 10.932  rs13479947 rs13479947 8 49.503 
rs6384194 rs6384194 1 11.319  rs3706149 rs3706149 8 50.061 
rs3695988 rs3695988 1 11.345  rs13479955 rs13479955 8 50.074 
rs4137502 rs4137502 1 11.461  rs3669235 rs3669235 8 50.253 
rs31837951 rs31837951 1 12.249  rs13479956 rs13479956 8 50.340 
rs3707642 rs3707642 1 12.426  rs3662808 rs3662808 8 56.991 
rs3681732 rs3681732 1 12.953  rs6237645 rs6237645 8 57.389 
rs3683997 rs3683997 1 14.842  gnf08.118.027 rs33401493 8 63.315 
rs4222295 rs4222295 1 17.369  rs3708073 rs3708073 8 70.716 
gnf01.036.770 rs13475823 1 18.581  rs6310696 rs6310696 8 70.824 
rs13475827 rs13475827 1 20.081  rs6377872 rs6377872 8 71.000 
rs13475834 rs13475834 1 20.661  rs3705725 rs3705725 8 72.309 
rs13475847 rs13475847 1 23.851  rs31833030 rs31833030 8 72.339 
rs13475851 rs13475851 1 25.709  gnf09.012.310 rs13480087 9 7.064 
CEL-1_49993068 rs31383619 1 25.876  rs13480092 rs13480092 9 7.305 
rs3724092 rs3724092 1 25.910  rs13480095 rs13480095 9 7.408 
rs13475866 rs13475866 1 26.334  rs8270115 rs8270115 9 7.927 
rs6322485 rs6322485 1 32.063  rs13480103 rs13480103 9 9.511 
rs3163007 rs3163007 1 32.307  rs3088801 rs3088801 9 10.106 
rs6288543 rs6288543 1 34.187  rs6404775 rs6404775 9 14.314 
rs6312657 rs6312657 1 34.680  rs6385855 rs6385855 9 15.145 
rs13475931 rs13475931 1 39.196  rs3655898 rs3655898 9 18.165 
rs13475934 rs13475934 1 39.511  UT_9_35.918713 rs30437276 9 20.114 




rs13475939 rs13475939 1 40.572  rs33646953 rs33646953 9 24.426 
rs13475946 rs13475946 1 41.565  rs13462199 rs13462199 9 24.739 
gnf01.079.218 rs13475952 1 42.110  rs13480173 rs13480173 9 25.485 
rs3723062 rs3723062 1 43.848  rs6395817 rs6395817 9 25.803 
UT_1_89.100476 rs32600524 1 44.067  gnf09.042.496 rs13480179 9 26.352 
rs6195073 rs6195073 1 44.700  rs13480186 rs13480186 9 27.114 
rs31435980 rs31435980 1 44.979  rs3723670 rs3723670 9 28.839 
rs13475980 rs13475980 1 46.189  rs13480208 rs13480208 9 29.932 
rs6268443 rs6268443 1 47.188  rs13480217 rs13480217 9 31.394 
rs3694065 rs3694065 1 48.814  rs6224703 rs6224703 9 32.333 
CEL-1_103251925 rs30596698 1 49.306  rs30458137 rs30458137 9 32.753 
CEL-1_105423103 rs31680156 1 49.601  rs3714012 rs3714012 9 33.180 
rs3685919 rs3685919 1 50.674  rs3655717 rs3655717 9 35.340 
rs13476061 rs13476061 1 50.919  rs6174757 rs6174757 9 36.954 
rs3674655 rs3674655 1 52.113  rs6355445 rs6355445 9 39.122 
rs3678634 rs3678634 1 52.718  rs3721056 rs3721056 9 39.700 
rs4137908 rs4137908 1 54.799  rs13480271 rs13480271 9 40.240 
rs13476104 rs13464873 1 55.969  rs33720457 rs33720457 9 40.876 
rs3699561 rs3699561 1 56.934  rs3724833 rs3724833 9 41.977 
rs3724826 rs3724826 1 57.000  rs13480285 rs13480285 9 42.583 
rs13476119 rs13476119 1 58.159  gnf09.074.193 rs13480298 9 43.863 
rs8250053 rs8250053 1 58.391  rs3676124 rs3676124 9 45.286 
gnf01.137.841 rs30968449 1 60.722  rs3695050 rs3695050 9 46.021 
rs13476141 rs13476141 1 61.841  rs3700596 rs3700596 9 46.512 
rs6382880 rs6382880 1 62.409  rs3669564 rs3669564 9 47.114 
rs13476152 rs13476152 1 62.560  gnf09.087.298 rs13480340 9 47.798 
rs3672697 rs3672697 1 63.104  rs13480345 rs13480345 9 48.379 
rs30986578 rs30986578 1 63.320  rs13480351 rs13480351 9 48.893 
rs6411476 rs6411476 1 63.404  CEL-9_95875215 rs29789189 9 50.284 
rs13476184 rs13476184 1 65.303  rs3689336 rs3689336 9 50.613 
UT_1_113.684537 rs31544365 1 67.667  rs13480365 rs13480365 9 51.376 
rs31299650 rs31299650 1 69.032  rs3717654 rs3717654 9 54.162 
rs13476229 rs13476229 1 76.767  rs30343415 rs30343415 9 55.078 
rs3707910 rs3707910 1 79.926  rs13480399 rs13480399 9 57.487 
rs3669108 rs3669108 1 81.044  rs13480407 rs13480407 9 59.514 
rs13476265 rs13476265 1 83.595  gnf09.110.002 rs13480428 9 63.934 
rs13476273 rs13476273 1 84.910  rs6320810 rs6320810 9 67.636 
rs3667164 rs3667164 1 93.199  rs3669563 rs3669563 9 69.841 
rs13476300 rs13476300 1 96.082  rs13459114 rs13459114 9 72.670 




rs27096879 rs27096879 2 2.238  rs6185923 rs6185923 10 0.438 
rs6213083 rs6213083 2 2.316  CEL-10_3989939 rs29368538 10 1.298 
rs4136817 rs4136817 2 2.515  rs3721803 rs3721803 10 1.696 
rs6359983 rs6359983 2 3.790  rs13480488 rs13480488 10 3.006 
rs6240512 rs6240512 2 8.426  rs3664101 rs3664101 10 3.154 
rs3674936 rs3674936 2 14.520  rs4228112 rs4228112 10 4.417 
rs13459062 rs13459062 2 21.806  rs13459187 rs13459187 10 5.143 
CEL-2_32981944 rs32868446 2 22.274  rs29329268 rs29329268 10 5.806 
gnf02.035.469 rs13476442 2 22.742  rs3699409 rs3699409 10 5.979 
rs13476439 rs13476439 2 24.323  rs13480521 rs13480521 10 7.861 
rs13476454 rs13476454 2 24.770  rs13459119 rs13459119 10 9.293 
rs13476467 rs13476467 2 26.974  rs13480534 rs13480534 10 9.796 
rs13476472 rs13476472 2 27.478  rs3679120 rs3679120 10 10.400 
rs6265423 rs6265423 2 27.693  rs13480547 rs13480547 10 11.755 
CEL-2_50605053 rs27901975 2 29.025  rs13480554 rs13480554 10 12.941 
rs3725341 rs3725341 2 29.897  gnf10.026.889 rs13480566 10 16.478 
rs13476503 rs13476503 2 30.511  rs13480578 rs13480578 10 18.922 
rs27929044 rs27929044 2 30.694  rs13480579 rs13480579 10 19.237 
rs3718711 rs3718711 2 31.734  rs13480601 rs13480601 10 23.190 
rs3672719 rs3672719 2 33.018  rs13480605 rs13480605 10 23.824 
CEL-2_63143553 rs33395966 2 36.722  rs3696307 rs3696307 10 27.314 
rs6222797 rs6222797 2 38.403  rs13480621 rs13480621 10 30.574 
rs4136610 rs4136610 2 41.073  rs13480627 rs13480627 10 34.736 
rs3664661 rs3664661 2 42.714  rs13480630 rs13480630 10 35.028 
rs13476580 rs13476580 2 44.165  CEL-10_71736974 rs29332616 10 37.031 
rs3722345 rs3722345 2 48.304  rs13480652 rs13480652 10 38.380 
rs3667007 rs3667007 2 49.029  rs13480657 rs13480657 10 38.917 
rs8273639 rs8273639 2 49.444  rs3717445 rs3717445 10 40.766 
rs13476621 rs13476621 2 49.887  rs13480678 rs13480678 10 41.500 
rs6404809 rs6404809 2 50.023  rs3679902 rs3679902 10 41.674 
rs13476636 rs13476636 2 50.636  rs3089366 rs3089366 10 45.073 
rs13476639 rs13476639 2 51.239  rs13480702 rs13480702 10 45.499 
rs13476649 rs13476649 2 52.255  rs29325765 rs29325765 10 47.050 
rs6378047 rs6378047 2 53.194  gnf10.091.965 rs13480710 10 47.545 
rs27359225 rs27359225 2 53.374  rs13480712 rs13480712 10 48.536 
rs13476666 rs13476666 2 53.746  rs13480716 rs13480716 10 48.973 
rs13476689 rs13476689 2 56.063  rs13480722 rs13480722 10 50.350 
rs13476691 rs13476691 2 56.306  rs3710293 rs3710293 10 51.414 
rs13476698 rs13476698 2 56.748  rs3688351 rs3688351 10 54.723 




rs4138562 rs4138562 2 57.704  rs6243755 rs6243755 10 56.692 
rs3699172 rs3699172 2 58.312  rs29353606 rs29353606 10 61.545 
rs3149106 rs3149106 2 59.399  rs3680872 rs3680872 10 61.556 
rs8279354 rs8279354 2 59.823  
CEL-
10_119602638 rs29360855 10 67.701 
rs3658927 rs3658927 2 60.369  rs3697243 rs3697243 10 73.832 
rs6228179 rs6228179 2 60.677  rs3676330 rs3676330 10 76.442 
rs6401493 rs6401493 2 61.384  rs13480836 rs13480836 11 2.495 
gnf02.126.027 rs13476762 2 62.081  rs13480837 rs13480837 11 2.735 
rs3661596 rs3661596 2 63.204  rs13480863 rs13480863 11 5.918 
rs3665528 rs3665528 2 63.278  rs26925478 rs26925478 11 6.126 
rs6363071 rs6363071 2 71.292  rs3023249 rs3023249 11 6.662 
rs6209325 rs6209325 2 73.369  rs13480875 rs13480875 11 7.335 
rs27349879 rs27349879 2 75.407  gnf11.017.294 rs29389113 11 10.513 
rs13476860 rs13476860 2 77.376  rs13480910 rs13480910 11 14.219 
rs3695266 rs3695266 2 78.550  rs3700830 rs3700830 11 17.794 
rs13476874 rs13476874 2 80.116  rs13459123 rs13459123 11 18.321 
rs3664408 rs3664408 2 81.738  rs26822994 rs26822994 11 18.868 
rs13476889 rs13476889 2 85.007  rs3723833 rs3723833 11 19.079 
CEL-2_168586738 rs27311433 2 88.761  rs13480968 rs13480968 11 22.232 
rs3726974 rs3726974 2 89.685  rs6359329 rs6359329 11 23.638 
rs13476928 rs13476928 2 97.782  rs13480996 rs13480996 11 25.809 
rs13476932 rs13476932 2 98.140  rs3654344 rs3654344 11 25.922 
rs3679483 rs3679483 2 102.647  rs26898753 rs26898753 11 27.389 
rs27681559 rs27681559 2 102.929  rs13481009 rs13481009 11 27.986 
rs13476963 rs13476963 3 2.104  rs13481011 rs13481011 11 28.080 
rs13476969 rs13476969 3 2.406  rs13481033 rs13481033 11 32.472 
rs13476973 rs13476973 3 2.935  rs4228731 rs4228731 11 33.040 
rs6248752 rs6248752 3 2.967  rs3684076 rs3684076 11 33.700 
rs13476985 rs13476985 3 3.230  rs3697686 rs3697686 11 36.250 
rs3659988 rs3659988 3 4.094  rs3711357 rs3711357 11 37.947 
gnf03.015.035 rs13476997 3 4.990  rs13481076 rs13481076 11 40.590 
rs6235984 rs6235984 3 7.393  rs6197743 rs6197743 11 42.960 
rs13477030 rs13477030 3 10.990  rs13481109 rs13481109 11 46.074 
rs3660588 rs3660588 3 13.426  rs13481119 rs13481119 11 46.826 
rs29807239 rs29807239 3 14.268  rs13481145 rs13481145 11 52.843 
rs13477043 rs13477043 3 15.290  rs3714299 rs3714299 11 58.424 
gnf03.030.222 rs29919622 3 16.101  rs27059631 rs27059631 11 58.900 
rs4223883 rs4223883 3 16.434  rs3661058 rs3661058 11 62.745 
rs6246699 rs6246699 3 17.452  rs6393948 rs6393948 11 67.403 




CEL-3_45598106 rs30263314 3 20.388  rs6386362 rs6386362 11 70.093 
rs13477097 rs13477097 3 21.275  rs6370458 rs6370458 11 71.910 
rs30057783 rs30057783 3 21.726  rs13481227 rs13481227 11 73.596 
rs4139913 rs4139913 3 21.749  rs3672597 rs3672597 11 75.820 
rs6241331 rs6241331 3 23.549  rs3699056 rs3699056 11 79.467 
rs4223969 rs4223969 3 26.260  rs13481256 rs13481256 11 82.957 
rs13477126 rs13477126 3 27.287  rs3712881 rs3712881 11 84.892 
rs13477138 rs13477138 3 29.092  rs13481303 rs13481303 12 5.626 
rs13477143 rs13477143 3 29.302  rs3706330 rs3706330 12 7.880 
rs13477154 rs13477154 3 30.058  rs13481321 rs13481321 12 7.923 
rs6212539 rs6212539 3 30.168  rs13481324 rs13481324 12 8.117 
rs31430997 rs31430997 3 30.245  rs3717860 rs3717860 12 8.495 
gnf03.063.824 rs13477167 3 30.735  rs13481363 rs13481363 12 10.543 
rs6198234 rs6198234 3 32.419  rs3089800 rs3089800 12 11.630 
rs6264454 rs6264454 3 32.571  rs13481371 rs13481371 12 12.768 
rs13477201 rs13477201 3 33.735  rs6223000 rs6223000 12 14.927 
rs3706378 rs3706378 3 33.755  rs13481388 rs13481388 12 15.533 
rs13477210 rs13477210 3 34.419  rs6311081 rs6311081 12 16.814 
rs13477217 rs13477217 3 34.881  rs3658100 rs3658100 12 17.537 
rs13477224 rs13477224 3 35.847  rs13481406 rs13481406 12 18.110 
rs13477233 rs13477233 3 37.284  rs13481408 rs13481408 12 18.369 
rs13477251 rs13477251 3 38.955  CEL-12_40646532 rs29148707 12 20.993 
rs13477268 rs13477268 3 40.211  rs3670749 rs3670749 12 22.242 
rs3022964 rs3022964 3 42.089  rs13481459 rs13481459 12 22.840 
rs3726226 rs3726226 3 42.961  rs3706319 rs3706319 12 25.397 
rs4138887 rs4138887 3 45.048  mCV22351241 rs29158995 12 25.941 
rs13477299 rs13477299 3 45.247  gnf12.061.363 rs13481496 12 26.705 
rs3701653 rs3701653 3 45.461  rs13481514 rs13481514 12 28.892 
rs29690864 rs29690864 3 47.761  rs13481527 rs13481527 12 30.340 
rs13477321 rs13477321 3 47.987  rs3655558 rs3655558 12 32.585 
rs3676545 rs3676545 3 48.528  rs13481541 rs13481541 12 33.626 
rs3698700 rs3698700 3 49.118  rs3662628 rs3662628 12 35.986 
gnf03.119.970 rs13477357 3 50.381  rs29176418 rs29176418 12 36.457 
rs3708412 rs3708412 3 50.969  rs13481565 rs13481565 12 38.807 
CEL-3_120379605 rs30157172 3 52.425  CEL-12_84750094 rs29184538 12 43.833 
rs13477404 rs13477404 3 60.271  rs3670410 rs3670410 12 44.326 
rs13477421 rs13477421 3 62.120  rs13481588 rs13481588 12 45.007 
rs30509660 rs30509660 3 63.036  rs13481592 rs13481592 12 45.198 
rs3676039 rs3676039 3 63.124  rs6207869 rs6207869 12 45.478 




rs3090379 rs3090379 3 66.233  rs13481604 rs13481604 12 49.820 
rs6290401 rs6290401 3 66.587  rs3716084 rs3716084 12 50.269 
rs3657112 rs3657112 3 72.448  rs13481614 rs13481614 12 51.183 
rs13477494 rs13477494 3 76.859  rs13481632 rs13481632 12 56.892 
rs13477506 rs13477506 3 79.346  rs6390948 rs6390948 12 59.558 
gnf03.160.599 rs30801216 3 81.070  rs13481655 rs13481655 12 61.147 
rs13477517 rs13477517 3 81.662  rs3023711 rs3023711 12 62.619 
CEL-3_159340478 rs30353245 3 82.066  mCV24244050 rs29249127 13 1.733 
rs3660863 rs3660863 4 3.374  rs6215262 rs6215262 13 2.100 
rs6287606 rs6287606 4 7.098  rs13481668 rs13481668 13 2.487 
rs27682879 rs27682879 4 7.532  rs13481673 rs13481673 13 2.837 
CEL-4_19508304 rs27682826 4 7.534  rs6348604 rs6348604 13 5.492 
rs13477596 rs13477596 4 8.599  rs3023379 rs3023379 13 6.365 
gnf04.019.134 rs13477602  4 9.709  rs13481715 rs13481715 13 6.898 
mCV22919271 rs27748877 4 10.325  rs6314295 rs6314295 13 7.214 
rs13477617 rs13477617 4 11.276  rs3705279 rs3705279 13 7.257 
rs3701432 rs3701432 4 12.487  rs3679784 rs3679784 13 7.543 
CEL-4_30653207 rs27801920 4 13.275  rs3663223 rs3663223 13 9.387 
rs3663744 rs3663744 4 13.517  rs13481767 rs13481767 13 16.310 
rs27807782 rs27807782 4 14.000  rs13481783 rs13481783 13 21.210 
rs3674908 rs3674908 4 14.005  rs3712907 rs3712907 13 21.327 
rs13477643 rs13477643 4 17.003  rs3688207 rs3688207 13 21.883 
rs3698283 rs3698283 4 23.004  rs6411274 rs6411274 13 24.301 
rs27856136 rs27856136 4 24.490  rs6244558 rs6244558 13 24.703 
rs3677770 rs3677770 4 29.364  rs3693942 rs3693942 13 29.453 
rs3712541 rs3712541 4 32.814  rs3690198 rs3690198 13 32.531 
rs27935605 rs27935605 4 33.958  rs4229817 rs4229817 13 34.532 
rs6254381 rs6254381 4 34.002  rs29730990 rs29730990 13 34.544 
rs13477838 rs13477838 4 42.520  rs13481871 rs13481871 13 37.601 
rs13477866 rs13477866 4 45.650  rs13481880 rs13481880 13 40.224 
rs28076769 rs28076769 4 45.667  rs13481883 rs13481883 13 40.871 
rs13477883 rs13477883 4 47.779  rs13481908 rs13481908 13 43.360 
rs6324470 rs6324470 4 49.475  rs29247893 rs29247893 13 43.678 
rs6226080 rs6226080 4 50.643  mCV24625340 rs29565666 13 44.743 
rs3710617 rs3710617 4 51.378  gnf13.088.732 rs29932904 13 45.235 
rs6381371 rs6381371 4 53.085  rs6288319 rs6288319 13 46.504 
rs3692563 rs3692563 4 54.658  rs6316213 rs6316213 13 47.483 
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gnf05.084.686 rs13478384 5 44.297  rs3692362 rs3692362 14 49.712 
rs3673049 rs3673049 5 44.318  CEL-14_94845626 rs30942806 14 52.610 
rs13478388 rs13478388 5 44.712  rs13482354 rs13482354 14 56.151 
rs6232866 rs6232866 5 45.474  rs3654132 rs3654132 14 56.158 
rs13478402 rs13478402 5 47.492  rs13482375 rs13482375 14 57.817 
CEL-5_93945748 rs29502845 5 47.559  rs6256423 rs6256423 14 58.780 
rs3661241 rs3661241 5 47.740  rs6169105 rs6169105 14 60.717 
rs3705458 rs3705458 5 48.326  rs3665550 rs3665550 14 62.625 
rs13478416 rs13478416 5 48.461  rs13482398 rs13482398 14 63.475 
rs13478451 rs13478451 5 53.197  rs13482407 rs13482407 14 65.852 
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CEL-5_117374791 rs32146173 5 60.445  rs13482431 rs13482431 15 5.575 
rs13478518 rs13478518 5 66.363  rs3711814 rs3711814 15 6.248 
rs13478540 rs13478540 5 74.362  CEL-15_14786403 rs31608298 15 7.706 
rs13478546 rs13478546 5 76.004  CEL-15_15482356 rs32187076 15 7.773 
rs4225536 rs4225536 5 77.062  rs13482455 rs13482455 15 7.869 
rs6298689 rs6298689 5 78.785  rs3715857 rs3715857 15 8.139 
rs3656197 rs3656197 5 80.281  rs13482477 rs13482477 15 8.543 
rs13478567 rs13478567 5 81.309  rs32275246 rs32275246 15 8.617 
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rs13479358 rs13479358 7 45.126  mCV23617245 rs30271401 18 8.002 
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rs3663988 rs3663988 7 84.321  rs3720876 rs3720876 18 53.237 
rs31198744 rs31198744 7 88.854  rs13483466 rs13483466 18 55.727 
rs6153168 rs6153168 8 3.092  mCV24836796 rs29667966 18 57.837 
rs3023176 rs3023176 8 7.587  rs13483482 rs13483482 18 58.209 
rs13479619 rs13479619 8 7.914  rs30456650 rs30456650 19 3.378 
rs3657963 rs3657963 8 8.446  rs6236348 rs6236348 19 4.441 
gnf08.014.711 rs13479625 8 9.266  UT_19_10.709331 rs30517739 19 7.103 
mCV24845756 rs33566717 8 10.583  rs6316813 rs6316813 19 8.177 
rs4140004 rs4140004 8 11.326  CEL-19_12595293 rs30697936 19 8.771 
rs3661760 rs3661760 8 11.480  rs31280015 rs31280015 19 10.150 
rs13479656 rs13479656 8 14.032  rs3686467 rs3686467 19 12.273 
rs13479673 rs13479673 8 16.533  rs30604569 rs30604569 19 13.204 
rs4227096 rs4227096 8 18.218  gnf19.017.711 rs13483556 19 13.705 
rs3706948 rs3706948 8 18.826  rs6309315 rs6309315 19 18.426 
rs13479701 rs13479701 8 22.382  rs6293693 rs6293693 19 20.923 
rs3665028 rs3665028 8 22.606  rs3090325 rs3090325 19 21.258 
rs3667738 rs3667738 8 23.504  rs30746021 rs30746021 19 21.788 
rs13479716 rs13479716 8 23.710  rs13459194 rs13459194 19 26.625 
rs3703811 rs3703811 8 23.870  rs6237466 rs6237466 19 27.057 
rs3666140 rs3666140 8 24.316  rs30396271 rs30396271 19 29.792 
rs6386110 rs6386110 8 24.757  CEL-19_34542259 rs30364728 19 29.987 
rs3719401 rs3719401 8 27.887  gnf19.035.019 rs30920120 19 32.228 
rs13479755 rs13479755 8 28.863  rs3655407 rs3655407 19 34.251 
CEL-8_51607005 rs31276910 8 29.030  rs30415214 rs30415214 19 35.972 




rs3707439 rs3707439 8 30.761  rs3687275 rs3687275 19 36.617 
rs3672639 rs3672639 8 30.936  rs13461374 rs13461374 19 36.698 
rs13479793 rs13479793 8 31.514  rs13483643 rs13483643 19 38.427 
rs13479794 rs13479794 8 31.550  rs3023496 rs3023496 19 41.195 
rs13479811 rs13479811 8 33.219  rs6304326 rs6304326 19 47.937 
rs3656875 rs3656875 8 33.567  rs30931570 rs30931570 19 48.458 
rs3699406 rs3699406 8 34.067  rs13483682 rs13483682 19 51.073 
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